https://zechmeister-solutions.com/en/blog In-depth guides on EU MDR certification for MedTech startups, written by Tibor Zechmeister (EU MDR Expert, Notified Body Lead Auditor) and Felix Lenhard. en-us Sat, 11 Apr 2026 07:59:50 +0000 build_blog.py https://zechmeister-solutions.com/en/blog/what-is-eu-mdr https://zechmeister-solutions.com/en/blog/what-is-eu-mdr The EU Medical Device Regulation (MDR 2017/745) is the legal framework governing how medical devices are designed, manufactured, and sold in Europe — here is what startups need to know. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-vs-mdd https://zechmeister-solutions.com/en/blog/mdr-vs-mdd The EU MDR replaced the MDD with stricter classification, clinical evidence, and oversight requirements — here are the specific changes that affect MedTech startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/complete-mdr-timeline https://zechmeister-solutions.com/en/blog/complete-mdr-timeline Every critical MDR milestone from adoption in 2017 through the extended transition periods — a complete timeline for MedTech startups planning their regulatory path in 2026. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/how-to-read-mdr https://zechmeister-solutions.com/en/blog/how-to-read-mdr A practical method for MedTech startup founders to read, understand, and work with the EU MDR (2017/745) without getting lost in 175 articles and 17 annexes. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-article-2-definitions https://zechmeister-solutions.com/en/blog/mdr-article-2-definitions Article 2 of the EU MDR contains over 70 definitions that determine your regulatory path — here are the 50 most critical terms for MedTech startups, explained in plain language. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-medical-device-under-mdr https://zechmeister-solutions.com/en/blog/what-is-medical-device-under-mdr The MDR definition of a medical device in Article 2(1) determines whether your product is regulated — here is exactly how to apply it to your startup's product. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-scope https://zechmeister-solutions.com/en/blog/mdr-scope The MDR scope in Article 1 defines which products are regulated — here is how to determine if your startup's product falls under the EU Medical Device Regulation. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medical-device-vs-wellness-product https://zechmeister-solutions.com/en/blog/medical-device-vs-wellness-product The line between a medical device and a wellness product under EU law depends on intended purpose — here is how to determine which category your startup's product falls into. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/borderline-products-mdr https://zechmeister-solutions.com/en/blog/borderline-products-mdr Many startup products sit on the boundary between medical device and non-medical product — here is how to determine your product's regulatory status under the EU MDR. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/beachhead-strategy https://zechmeister-solutions.com/en/blog/beachhead-strategy Launching your product as a wellness device before pursuing MDR certification is a legitimate go-to-market strategy — here is how to do it correctly and what traps to avoid. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-i-gspr https://zechmeister-solutions.com/en/blog/mdr-annex-i-gspr Annex I of the MDR contains the General Safety and Performance Requirements (GSPRs) that every medical device must meet — here is how startups should approach them systematically. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/essential-requirements-vs-gspr https://zechmeister-solutions.com/en/blog/essential-requirements-vs-gspr The MDR replaced the MDD's Essential Requirements with General Safety and Performance Requirements (GSPRs) — here are the specific changes and what they mean for your compliance strategy. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-ecosystem-key-players https://zechmeister-solutions.com/en/blog/mdr-ecosystem-key-players The MDR ecosystem includes competent authorities, Notified Bodies, the European Commission, and the MDCG — here is who they are, what they do, and how they affect your startup. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-notified-body https://zechmeister-solutions.com/en/blog/what-is-notified-body Notified Bodies are the organizations that audit your medical device and issue your CE marking certificate — here is how they work, what they look for, and how to prepare. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/choose-right-notified-body https://zechmeister-solutions.com/en/blog/choose-right-notified-body Choosing the right Notified Body affects your timeline, costs, and audit experience — here is how to evaluate and select the best Notified Body for your startup's device. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/notified-body-bottleneck https://zechmeister-solutions.com/en/blog/notified-body-bottleneck Notified Body capacity constraints create 6-18 month wait times for MDR certification — here are practical strategies for startups to manage and mitigate the bottleneck. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-competent-authority https://zechmeister-solutions.com/en/blog/what-is-competent-authority Competent authorities enforce the MDR in each EU member state — here is what they do, how they affect your startup, and when you need to interact with them. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/european-commission-mdr https://zechmeister-solutions.com/en/blog/european-commission-mdr The European Commission shapes MDR implementation through EUDAMED, common specifications, harmonized standards, and implementing acts — here is what startups need to know. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-article-5-placing-on-market https://zechmeister-solutions.com/en/blog/mdr-article-5-placing-on-market MDR Article 5 defines the conditions for placing medical devices on the EU market — here is what it requires and how startups should prepare for market entry. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/manufacturer-mdr-article-2-30 https://zechmeister-solutions.com/en/blog/manufacturer-mdr-article-2-30 The MDR definition of 'manufacturer' in Article 2(30) carries extensive legal obligations — here is what it means for startup founders who outsource production or use contract manufacturers. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/authorized-representatives https://zechmeister-solutions.com/en/blog/authorized-representatives Non-EU manufacturers must appoint an authorized representative under MDR Article 11 to place medical devices on the EU market — here is when you need one and how to select the right partner. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-importers-distributors https://zechmeister-solutions.com/en/blog/mdr-importers-distributors Importers and distributors have specific MDR obligations that affect how startups structure their sales channels — here is what each role requires and how it impacts your go-to-market strategy. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prrc-mdr-article-15 https://zechmeister-solutions.com/en/blog/prrc-mdr-article-15 MDR Article 15 requires every manufacturer to designate a Person Responsible for Regulatory Compliance (PRRC) with specific qualifications — here is what startups need to know. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prrc-options-startups https://zechmeister-solutions.com/en/blog/prrc-options-startups Startups qualifying as micro or small enterprises can use an external PRRC under MDR Article 15 — here are the practical options, costs, and trade-offs for meeting this requirement. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-transition-periods https://zechmeister-solutions.com/en/blog/mdr-transition-periods The MDR transition periods have been extended by Regulation (EU) 2023/607 — here is what still applies in 2026, which deadlines are approaching, and how they affect your startup. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-amendment-2023-607-extended-transition-periods https://zechmeister-solutions.com/en/blog/mdr-amendment-2023-607-extended-transition-periods Complete breakdown of the MDR amendment (EU) 2023/607 that extended transition periods for legacy medical devices. Learn what changed, new deadlines, and what it means for your MedTech startup. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ce-marking-under-mdr-step-by-step-process https://zechmeister-solutions.com/en/blog/ce-marking-under-mdr-step-by-step-process The complete step-by-step CE marking process under EU MDR 2017/745 for medical device startups. From device classification to declaration of conformity — every stage explained from the startup perspective. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/how-long-does-ce-mark-take-honest-timelines https://zechmeister-solutions.com/en/blog/how-long-does-ce-mark-take-honest-timelines Realistic CE marking timelines for medical device startups under EU MDR. Honest breakdowns by device class, with typical delays and what actually drives the timeline. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-does-ce-marking-cost-startup-transparent-breakdown https://zechmeister-solutions.com/en/blog/what-does-ce-marking-cost-startup-transparent-breakdown Transparent cost breakdown for CE marking under EU MDR for medical device startups. Real numbers for QMS, testing, Notified Body fees, clinical evaluation, and regulatory consulting by device class. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/minimum-viable-regulatory-strategy-ce-mark-limited-resources https://zechmeister-solutions.com/en/blog/minimum-viable-regulatory-strategy-ce-mark-limited-resources How MedTech startups with limited budgets and small teams can build a lean but compliant regulatory strategy to reach CE marking under EU MDR. Practical frameworks for prioritizing what matters. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-conformity-assessment-routes-which-path-right-device https://zechmeister-solutions.com/en/blog/mdr-conformity-assessment-routes-which-path-right-device Complete guide to MDR conformity assessment procedures under Annexes IX, X, and XI. How to choose the right route for your medical device class and why it matters for startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/self-certification-under-mdr-ce-mark-without-notified-body https://zechmeister-solutions.com/en/blog/self-certification-under-mdr-ce-mark-without-notified-body When and how medical device startups can self-certify under EU MDR without a Notified Body. Class I self-certification requirements, responsibilities, and common pitfalls explained. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eu-declaration-of-conformity-mdr-what-to-include https://zechmeister-solutions.com/en/blog/eu-declaration-of-conformity-mdr-what-to-include How to write the EU Declaration of Conformity under MDR Annex IV. Required content, format guidance, common mistakes, and practical templates for medical device startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/free-sale-certificates-what-they-are-when-startup-needs-them https://zechmeister-solutions.com/en/blog/free-sale-certificates-what-they-are-when-startup-needs-them What free sale certificates are, when MedTech startups need them, how to obtain them, and their role in international market access beyond the EU under MDR. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-custom-made-devices-rules-personalized-medtech https://zechmeister-solutions.com/en/blog/mdr-custom-made-devices-rules-personalized-medtech MDR rules for custom-made medical devices explained for startups. Understand the definition, documentation requirements, and conformity path for personalized and patient-specific devices. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rules-devices-no-intended-medical-purpose-annex-xvi https://zechmeister-solutions.com/en/blog/mdr-rules-devices-no-intended-medical-purpose-annex-xvi Complete guide to MDR Annex XVI devices — products with no medical purpose that fall under medical device regulation. Aesthetic devices, colored contact lenses, brain stimulation, and more. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-specifications-under-mdr-what-they-are-startups https://zechmeister-solutions.com/en/blog/common-specifications-under-mdr-what-they-are-startups What Common Specifications are under EU MDR, when they apply, how they differ from harmonized standards, and what MedTech startups need to know to comply. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/harmonized-standards-under-mdr-complete-list-2026 https://zechmeister-solutions.com/en/blog/harmonized-standards-under-mdr-complete-list-2026 Complete overview of harmonized standards under EU MDR in 2026. Which standards are harmonized, how to check their status, and what the gaps mean for MedTech startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/how-to-use-harmonized-standards-demonstrate-mdr-compliance https://zechmeister-solutions.com/en/blog/how-to-use-harmonized-standards-demonstrate-mdr-compliance Practical guide for MedTech startups on using harmonized standards to demonstrate compliance with EU MDR General Safety and Performance Requirements. GSPR mapping, documentation, and Notified Body expectations. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/state-of-the-art-principle-mdr-design-decisions https://zechmeister-solutions.com/en/blog/state-of-the-art-principle-mdr-design-decisions What 'state of the art' means under EU MDR, how it affects medical device design, and how startups can demonstrate they meet this critical requirement. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-article-61-clinical-evidence-requirements-startups https://zechmeister-solutions.com/en/blog/mdr-article-61-clinical-evidence-requirements-startups Deep dive into MDR Article 61 clinical evidence requirements for medical devices. What startups get wrong about clinical evaluation, equivalence, and clinical investigations. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-mdr-auditor-perspective https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-mdr-auditor-perspective How Notified Body auditors evaluate 'sufficient clinical evidence' under EU MDR. Insider perspective on what passes, what fails, and what startups can do to meet the bar. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-penalties-market-surveillance-what-happens-wrong https://zechmeister-solutions.com/en/blog/mdr-penalties-market-surveillance-what-happens-wrong What happens when a medical device manufacturer violates EU MDR. Market surveillance actions, penalties, recalls, and enforcement consequences explained for startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ten-most-common-mdr-non-conformities-startup-audits https://zechmeister-solutions.com/en/blog/ten-most-common-mdr-non-conformities-startup-audits The 10 most frequent non-conformities Notified Body auditors find in MedTech startup audits under EU MDR. What they are, why they happen, and how to prevent them. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-accessories-add-on-product-regulated-device https://zechmeister-solutions.com/en/blog/mdr-accessories-add-on-product-regulated-device How EU MDR regulates medical device accessories. Definition, classification rules, and compliance requirements for startups building add-on products that work with medical devices. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/combination-products-mdr-drug-device-biologic-device-rules https://zechmeister-solutions.com/en/blog/combination-products-mdr-drug-device-biologic-device-rules How EU MDR handles combination products — drug-device and biologic-device combinations. Regulatory pathways, classification, and practical guidance for MedTech startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-and-brexit-selling-medical-devices-uk-eu-startup https://zechmeister-solutions.com/en/blog/mdr-and-brexit-selling-medical-devices-uk-eu-startup How Brexit changed medical device regulation for EU startups selling to the UK. UKCA marking, CE marking recognition, UK Approved Bodies, and practical market access strategies. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ukca-marking-vs-ce-marking-eu-startups-2026 https://zechmeister-solutions.com/en/blog/ukca-marking-vs-ce-marking-eu-startups-2026 Side-by-side comparison of UKCA marking and CE marking for medical devices. Key differences, practical implications, and dual-marking strategies for EU MedTech startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-vs-fda-key-differences-eu-us-medical-device-regulation https://zechmeister-solutions.com/en/blog/mdr-vs-fda-key-differences-eu-us-medical-device-regulation Side-by-side comparison of EU MDR and US FDA medical device regulation. Key differences in classification, approval pathways, clinical evidence, and post-market requirements for startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-strategy-startups-targeting-eu-us-markets https://zechmeister-solutions.com/en/blog/regulatory-strategy-startups-targeting-eu-us-markets How MedTech startups can build a regulatory strategy for simultaneous EU MDR and US FDA market access. Dual-market planning, documentation synergies, and practical sequencing advice. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/two-phase-development-approach https://zechmeister-solutions.com/en/blog/two-phase-development-approach Documenting everything MDR-compliant from day one kills startup speed. The two-phase approach: prove feasibility first, then certify what works. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/when-to-start-mdr-regulatory-work https://zechmeister-solutions.com/en/blog/when-to-start-mdr-regulatory-work The right time to start MDR work is not day one and not after prototype. It is the moment your intended purpose stabilizes. Here is the founder's timeline. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/notified-body-auditor-perspective https://zechmeister-solutions.com/en/blog/notified-body-auditor-perspective What do Notified Body auditors actually look for during an MDR audit? A lead auditor and founder explains what matters and what doesn't. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prepare-for-first-notified-body-audit https://zechmeister-solutions.com/en/blog/prepare-for-first-notified-body-audit Your first notified body audit is not an exam. It is a structured conversation about whether your QMS and technical file match reality. Here is how to prepare. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/stage-1-vs-stage-2-audit-mdr https://zechmeister-solutions.com/en/blog/stage-1-vs-stage-2-audit-mdr Stage 1 is a documentation and readiness review. Stage 2 is the on-site operational assessment. Here is what happens in each, and how to prepare. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/unannounced-audits-under-mdr https://zechmeister-solutions.com/en/blog/unannounced-audits-under-mdr Notified Bodies are required to carry out unannounced on-site audits of manufacturers under MDR. Here is what they look for and how to stay audit-ready every day. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/respond-to-mdr-audit-nonconformities https://zechmeister-solutions.com/en/blog/respond-to-mdr-audit-nonconformities Your Notified Body audit came back with nonconformities. Here is the CAPA response process that closes them out without triggering new findings. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/both-sides-perspective-auditor-entrepreneur https://zechmeister-solutions.com/en/blog/both-sides-perspective-auditor-entrepreneur What does MDR look like from both sides of the audit table? Tibor Zechmeister has spent 15 years as a founder and as a lead auditor. Here is what that dual view teaches. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-regulatory-updates-2026 https://zechmeister-solutions.com/en/blog/mdr-regulatory-updates-2026 What changed in the MDR landscape at the turn of 2026: MDCG 2025-10 on PMS, ISO 10993-1:2025, the ISO 14155 amendment, and what they mean for startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-regulatory-outlook-2027 https://zechmeister-solutions.com/en/blog/mdr-regulatory-outlook-2027 What is coming in the MDR landscape in 2027: the end of transitional provisions, the MDR review cycle, pending MDCG guidance, and how founders should prepare now. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/15-mdr-myths-that-waste-startup-time-and-money https://zechmeister-solutions.com/en/blog/15-mdr-myths-that-waste-startup-time-and-money Fifteen MDR myths that show up in almost every first meeting with a MedTech founder — and the regulatory reality behind each one, with the article references. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/diy-vs-mdr-consultant https://zechmeister-solutions.com/en/blog/diy-vs-mdr-consultant When should a MedTech startup do MDR work in-house and when should they hire a consultant? A decision framework plus how to spot charlatans. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/no-bullshit-mdr-guide-first-time-founders https://zechmeister-solutions.com/en/blog/no-bullshit-mdr-guide-first-time-founders A direct, honest guide to MDR compliance for first-time MedTech founders. No jargon, no fluff, no hidden complexity. The real path from zero to CE mark. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-regulatory-roadmap-startup https://zechmeister-solutions.com/en/blog/mdr-regulatory-roadmap-startup Your MDR regulatory roadmap is the sequence of decisions and deliverables from intended purpose to CE mark. Here is the template that actually works for startups. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/subtract-to-ship-framework-mdr https://zechmeister-solutions.com/en/blog/subtract-to-ship-framework-mdr The Subtract to Ship framework applied to MDR: strip every activity, document, and feature that does not trace back to a specific MDR article. Less work, more certification. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-device-classification-explained https://zechmeister-solutions.com/en/blog/mdr-device-classification-explained The MDR classifies medical devices into Class I, IIa, IIb, and III by risk. Here is the step-by-step classification process and the Annex VIII rules that drive it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-viii-classification-rules-complete-guide https://zechmeister-solutions.com/en/blog/mdr-annex-viii-classification-rules-complete-guide MDR Annex VIII contains 22 classification rules. Here is the complete guide to how they work, grouped by device family, with the traps startups miss. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/class-i-medical-devices-under-mdr https://zechmeister-solutions.com/en/blog/class-i-medical-devices-under-mdr Class I is the lightest MDR path, but it is not a free pass. Here is what Class I actually requires, what self-certification means, and when you still need a Notified Body. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/class-iia-medical-devices-under-mdr https://zechmeister-solutions.com/en/blog/class-iia-medical-devices-under-mdr Class IIa devices require Notified Body involvement under MDR. Here are the three conformity assessment routes, the requirements, and what the NB actually checks. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/class-iib-medical-devices-under-mdr https://zechmeister-solutions.com/en/blog/class-iib-medical-devices-under-mdr Class IIb under MDR is a meaningful step up in regulatory burden from IIa. Here is what Class IIb actually requires, the conformity routes, and what founders underestimate. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/class-iii-medical-devices-under-mdr https://zechmeister-solutions.com/en/blog/class-iii-medical-devices-under-mdr Class III is the highest MDR risk category. Here is what it requires, including the Article 54/55 consultation procedures, and whether your startup should even try. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-1-non-invasive-devices https://zechmeister-solutions.com/en/blog/mdr-rule-1-non-invasive-devices MDR Annex VIII Rule 1 classifies non-invasive devices that do not contact the patient or contact only intact skin. Here is how to apply it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-2-channeling-storing-administration https://zechmeister-solutions.com/en/blog/mdr-rule-2-channeling-storing-administration MDR Annex VIII Rule 2 classifies non-invasive devices that channel or store substances for administration. Here is how to apply it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rules-3-4-modify-biological-chemical-composition https://zechmeister-solutions.com/en/blog/mdr-rules-3-4-modify-biological-chemical-composition MDR Annex VIII Rules 3 and 4 cover non-invasive devices that modify biological or chemical composition. Here is how to apply them. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-5-invasive-body-orifices https://zechmeister-solutions.com/en/blog/mdr-rule-5-invasive-body-orifices MDR Annex VIII Rule 5 classifies invasive devices used in body orifices, by duration of use. Here is how to apply it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-6-surgically-invasive-transient https://zechmeister-solutions.com/en/blog/mdr-rule-6-surgically-invasive-transient MDR Annex VIII Rule 6 classifies surgically invasive devices for transient use. Here is how to apply it and the escalation conditions. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-7-short-term-surgically-invasive https://zechmeister-solutions.com/en/blog/mdr-rule-7-short-term-surgically-invasive MDR Annex VIII Rule 7 classifies surgically invasive devices intended for short-term use. Here is how to apply it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-8-long-term-implantable https://zechmeister-solutions.com/en/blog/mdr-rule-8-long-term-implantable MDR Annex VIII Rule 8 covers implantable and long-term surgically invasive devices. Here is how to apply it and the Class III escalations. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-9-active-therapeutic https://zechmeister-solutions.com/en/blog/mdr-rule-9-active-therapeutic MDR Annex VIII Rule 9 classifies active therapeutic devices by the energy exchange they mediate. Here is how to apply it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-10-active-diagnostic https://zechmeister-solutions.com/en/blog/mdr-rule-10-active-diagnostic MDR Annex VIII Rule 10 classifies active diagnostic and monitoring devices. Here is how to apply the IIa baseline and the IIb escalations. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-classification-rule-11-software https://zechmeister-solutions.com/en/blog/mdr-classification-rule-11-software MDR Annex VIII Rule 11 classifies most medical device software as Class IIa or higher. Here is how to apply Rule 11 correctly and when Class IIb or III applies. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-12-active-devices-medicinal-products https://zechmeister-solutions.com/en/blog/mdr-rule-12-active-devices-medicinal-products MDR Annex VIII Rule 12 classifies active devices that administer or exchange medicinal products. Here is how to apply it correctly. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rule-13-devices-incorporating-medicinal-substance https://zechmeister-solutions.com/en/blog/mdr-rule-13-devices-incorporating-medicinal-substance MDR Annex VIII Rule 13 covers devices that incorporate a medicinal substance. Here is how to apply it and the combination-product boundary. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-rules-14-22-special-rules https://zechmeister-solutions.com/en/blog/mdr-rules-14-22-special-rules MDR Annex VIII Rules 14 to 22 cover special cases — substances, nanomaterials, blood, disinfectants, contact lenses, and more. Here is what each rule does. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-classification-software-rule-11-deep-dive https://zechmeister-solutions.com/en/blog/mdr-classification-software-rule-11-deep-dive A deep dive into MDR Annex VIII Rule 11 for SaMD startups — each branch, each threshold, each real-world classification call. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdcg-software-classification-examples-startups https://zechmeister-solutions.com/en/blog/mdcg-software-classification-examples-startups MDCG 2019-11 Rev.1 contains worked examples for software classification. Here are the ones that matter most for MedTech startups, with the reasoning explained. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/device-classified-higher-mdr-than-mdd https://zechmeister-solutions.com/en/blog/device-classified-higher-mdr-than-mdd Many devices end up in a higher class under MDR than they were under MDD. Here are the rule changes that drive upclassification and how to respond. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/up-classification-mdr-handling https://zechmeister-solutions.com/en/blog/up-classification-mdr-handling When MDR up-classifies your device higher than expected, the workload jumps and the timeline shifts. Here is how to absorb the surprise without losing the project. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/classification-disputes-notified-body https://zechmeister-solutions.com/en/blog/classification-disputes-notified-body When a Notified Body classifies your device higher than you expect, you can argue the case. Here is how to prepare the evidence and the conversation. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-ix-qms-conformity-assessment https://zechmeister-solutions.com/en/blog/mdr-annex-ix-qms-conformity-assessment Annex IX is the full QMS plus technical documentation assessment route under MDR. Here is how it works and what the Notified Body actually assesses. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-x-type-examination https://zechmeister-solutions.com/en/blog/mdr-annex-x-type-examination MDR Annex X type examination is one of the conformity assessment routes for higher-class devices. Here is when it applies and how it differs from Annex IX. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-xi-production-quality-assurance https://zechmeister-solutions.com/en/blog/mdr-annex-xi-production-quality-assurance MDR Annex XI is the production-side conformity assessment route, paired with Annex X type examination. Here is how it works. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/choosing-conformity-assessment-route-startup https://zechmeister-solutions.com/en/blog/choosing-conformity-assessment-route-startup MDR offers several conformity assessment routes by device class. Here is how to choose the right one and the trade-offs that matter for startups. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/conformity-assessment-class-i-checklist https://zechmeister-solutions.com/en/blog/conformity-assessment-class-i-checklist The Class I self-certification path is the lightest under MDR, but still has specific steps. Here is the startup checklist from intended purpose to declaration of conformity. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iia-step-by-step https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iia-step-by-step Class IIa conformity assessment under MDR involves a Notified Body. Here is the step-by-step procedure from QMS preparation to certificate issuance. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iib https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iib Class IIb conformity assessment under MDR is a heavier version of the IIa process. Here is what to expect step by step. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iii https://zechmeister-solutions.com/en/blog/conformity-assessment-class-iii Class III conformity assessment under MDR is the heaviest pathway, including Article 54/55 consultation procedures. Here is the full process. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/conformity-assessment-samd-startup https://zechmeister-solutions.com/en/blog/conformity-assessment-samd-startup SaMD conformity assessment follows the same MDR routes as any other device but with software-specific scrutiny. Here is the startup path from Rule 11 to certificate. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/classification-justification-document-mdr https://zechmeister-solutions.com/en/blog/classification-justification-document-mdr An MDR classification justification document names the intended purpose, walks every Annex VIII rule, and lands one class. Here is how to write one. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/intended-purpose-vs-intended-use-mdr https://zechmeister-solutions.com/en/blog/intended-purpose-vs-intended-use-mdr Intended purpose is the manufacturer's legal statement of what the device is for. Intended use is what users actually do with it. The gap is where MDR trouble starts. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/intended-purpose-drives-regulatory-decisions https://zechmeister-solutions.com/en/blog/intended-purpose-drives-regulatory-decisions Your intended purpose statement decides classification, GSPR scope, clinical evidence, and labeling under MDR. One sentence, every downstream cost. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/claims-management-mdr https://zechmeister-solutions.com/en/blog/claims-management-mdr MDR claims management for medical devices: what Article 7 allows, what it forbids, and how to run a claims register that survives a Notified Body audit. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/off-label-use-mdr-manufacturers https://zechmeister-solutions.com/en/blog/off-label-use-mdr-manufacturers Off-label use is a clinician's call, not the manufacturer's. But the moment you promote, hint at, or ignore it, MDR liability crosses the line onto you. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/multi-function-devices-classification https://zechmeister-solutions.com/en/blog/multi-function-devices-classification When a device performs multiple functions, multiple Annex VIII rules apply and the highest class wins. Here is how to apply the implementing rule correctly. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/classification-startup-pivots https://zechmeister-solutions.com/en/blog/classification-startup-pivots When a startup pivots its intended purpose, the MDR classification may change. Here is what that triggers, from re-assessment to new NB engagement. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/nb-opinion-mdr-article-54 https://zechmeister-solutions.com/en/blog/nb-opinion-mdr-article-54 MDR Article 54 requires a clinical evaluation consultation for certain Class III implantable and Class IIb active devices. Here is when it triggers and what it means. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/scrutiny-procedure-mdr-article-55 https://zechmeister-solutions.com/en/blog/scrutiny-procedure-mdr-article-55 MDR Article 55 sets out the scrutiny mechanism for certain Class III implantable and Class IIb active devices. Here is how it works in practice. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/minimize-device-classification-mdr https://zechmeister-solutions.com/en/blog/minimize-device-classification-mdr The lowest defensible MDR class for your device is the one with the smallest regulatory burden you can honestly justify. Here is how to find it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/7-classification-mistakes-startups-make-under-mdr https://zechmeister-solutions.com/en/blog/7-classification-mistakes-startups-make-under-mdr The seven most common MDR classification mistakes that cost startups months of rework — each with the Annex VIII rule it violates and how to avoid it. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/strategic-approach-classification-plan-before-build https://zechmeister-solutions.com/en/blog/strategic-approach-classification-plan-before-build Classification should be decided before the first prototype — not after. Here is the strategic approach that keeps your regulatory burden proportionate to your runway. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-clinical-evaluation-under-mdr https://zechmeister-solutions.com/en/blog/what-is-clinical-evaluation-under-mdr Clinical evaluation is the ongoing process of generating, collecting, and assessing clinical data on safety and performance. Here is what MDR Article 61 actually requires. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-article-61-clinical-evaluation-requirements https://zechmeister-solutions.com/en/blog/mdr-article-61-clinical-evaluation-requirements MDR Article 61 is the heart of clinical evaluation. Here is the article decoded paragraph by paragraph, with what each requirement actually means for startups. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-vs-clinical-investigation https://zechmeister-solutions.com/en/blog/clinical-evaluation-vs-clinical-investigation Clinical evaluation is the ongoing process. Clinical investigation is a specific study. Conflating them wastes months. Here is the distinction every MedTech founder must understand. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-process-mdr https://zechmeister-solutions.com/en/blog/clinical-evaluation-process-mdr The MDR clinical evaluation process runs from CEP through CER to PMCF in a defined sequence. Here is the step-by-step guide for startups. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-xiv-part-a-clinical-evaluation https://zechmeister-solutions.com/en/blog/mdr-annex-xiv-part-a-clinical-evaluation MDR Annex XIV Part A sets out the exact clinical evaluation process. Here is what each section requires — scope, data identification, appraisal, and analysis. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/write-clinical-evaluation-plan-cep-mdr https://zechmeister-solutions.com/en/blog/write-clinical-evaluation-plan-cep-mdr The CEP is the first document in your MDR clinical evaluation. Here is what it must contain, section by section, with the Annex XIV Part A references. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-report-cer-mdr https://zechmeister-solutions.com/en/blog/clinical-evaluation-report-cer-mdr The CER is the central clinical document in the technical file. Here is the structure, the mandatory content, and the mistakes that trigger nonconformities. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/systematic-literature-review-clinical-evaluation https://zechmeister-solutions.com/en/blog/systematic-literature-review-clinical-evaluation A systematic literature review is the backbone of most MedTech clinical evaluations. Here is how to scope, execute, and document it so the Notified Body accepts it. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/appraisal-clinical-data-mdr https://zechmeister-solutions.com/en/blog/appraisal-clinical-data-mdr Appraising clinical data means grading each source for relevance and methodological quality. Here is how to do it under MDR in a way auditors accept. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/equivalence-under-mdr https://zechmeister-solutions.com/en/blog/equivalence-under-mdr MDR equivalence requires demonstration across technical, biological, and clinical characteristics. Here is what MDCG 2020-5 demands and why most claims fail. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/three-pillars-equivalence https://zechmeister-solutions.com/en/blog/three-pillars-equivalence MDR equivalence requires demonstration across technical, biological, and clinical characteristics — all three, not one or two. Here is how each pillar is defined and tested. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/equivalence-harder-mdr-than-mdd https://zechmeister-solutions.com/en/blog/equivalence-harder-mdr-than-mdd Equivalence claims are stricter under MDR than under MDD. Here is what changed, why it changed, and how startups should adapt their clinical evaluation strategy. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cannot-claim-equivalence-generate-data https://zechmeister-solutions.com/en/blog/cannot-claim-equivalence-generate-data If equivalence fails, you have to generate your own clinical data. Here is how to recognise that moment and plan the investigation that follows. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-data-sources-mdr https://zechmeister-solutions.com/en/blog/clinical-data-sources-mdr MDR recognises three main sources of clinical data: literature, equivalence, and clinical investigations. Here is how to choose and combine them. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/meddev-271-rev4-mdr-relevance https://zechmeister-solutions.com/en/blog/meddev-271-rev4-mdr-relevance MEDDEV 2.7/1 Rev 4 is legacy MDD guidance. Is it still useful under MDR in 2026? Here is the honest answer with concrete examples of what still applies. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdcg-guidance-clinical-evaluation https://zechmeister-solutions.com/en/blog/mdcg-guidance-clinical-evaluation MDCG has published key clinical evaluation guidance documents that clarify MDR Article 61. Here are the main MDCG documents for startups and how to apply them. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-i-devices https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-i-devices Class I devices still need clinical evaluation under MDR Article 61. Here is what counts as sufficient evidence — and the story of how one company saved EUR 400-500K. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-iia https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-iia Class IIa devices need more clinical evidence than Class I, but not as much as IIb or III. Here is the proportionate evidence bar with concrete examples. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-iib-iii https://zechmeister-solutions.com/en/blog/sufficient-clinical-evidence-class-iib-iii Class IIb and Class III devices face a higher clinical evidence bar under MDR. Here is what proportionate evidence looks like at the top end. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-samd https://zechmeister-solutions.com/en/blog/clinical-evaluation-samd Clinical evaluation for SaMD has the same MDR Article 61 backbone but unique data sources and validation methods. Here is what to know. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-ai-ml-continuous-learning https://zechmeister-solutions.com/en/blog/clinical-evaluation-ai-ml-continuous-learning Continuously learning AI complicates clinical evaluation. Here is how to scope the CE for adaptive algorithms under MDR Article 61. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-clinical-investigation-mdr https://zechmeister-solutions.com/en/blog/what-is-clinical-investigation-mdr A clinical investigation under MDR is a formal study on human subjects. Here is when you need one, what the MDR requires, and when you can avoid one. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-chapter-vi-clinical-investigations https://zechmeister-solutions.com/en/blog/mdr-chapter-vi-clinical-investigations MDR Chapter VI (Articles 62-82) is the full regulatory framework for clinical investigations. Here is the chapter walkthrough for startup sponsors. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-clinical-investigation-startup https://zechmeister-solutions.com/en/blog/design-clinical-investigation-startup Designing a startup clinical investigation under MDR means scoping to answer the specific clinical question with the smallest viable study. Here is the design framework. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/write-clinical-investigation-plan-cip https://zechmeister-solutions.com/en/blog/write-clinical-investigation-plan-cip The CIP is the blueprint for your MDR clinical investigation. Here is what Article 62(4) and Annex XV require in it — section by section. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ethics-committee-clinical-investigations-mdr https://zechmeister-solutions.com/en/blog/ethics-committee-clinical-investigations-mdr MDR clinical investigations need ethics committee approval. Here is what the committee checks and how to prepare the submission. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/informed-consent-mdr-article-63 https://zechmeister-solutions.com/en/blog/informed-consent-mdr-article-63 MDR Article 63 sets the informed consent rules for clinical investigations. Here is what the consent form must contain and how to draft it. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sponsor-obligations-clinical-investigations-mdr https://zechmeister-solutions.com/en/blog/sponsor-obligations-clinical-investigations-mdr MDR Article 62(4) sets out what the sponsor of a clinical investigation must do. Here is the obligations list and how it lands on a startup sponsor. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-investigation-approval-application https://zechmeister-solutions.com/en/blog/clinical-investigation-approval-application MDR clinical investigation approval application: Annex XV dossier contents, Article 70 timelines, and multi-state coordination for startup sponsors. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-investigation-financial-compensation-insurance https://zechmeister-solutions.com/en/blog/clinical-investigation-financial-compensation-insurance MDR Article 62(4)(g) requires sponsors to arrange financial compensation and insurance for clinical investigation subjects. Here is what that means in practice. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/adverse-event-reporting-clinical-investigations https://zechmeister-solutions.com/en/blog/adverse-event-reporting-clinical-investigations MDR Article 80 defines the adverse event reporting obligations during clinical investigations. Here is the timeline, the reportability, and how to operate it. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-investigation-report-mdr https://zechmeister-solutions.com/en/blog/clinical-investigation-report-mdr MDR Article 77 requires a clinical investigation report after the study completes. Here is what to include and the publication obligation. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/first-in-human-studies-mdr https://zechmeister-solutions.com/en/blog/first-in-human-studies-mdr A first-in-human study under MDR demands extra pre-clinical evidence, sponsor rigour, and ethics oversight. Here is what Article 62 actually requires. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/lean-clinical-investigation-startup https://zechmeister-solutions.com/en/blog/lean-clinical-investigation-startup A MedTech clinical investigation does not have to cost millions. Here is how to scope a lean, GCP-compliant study that satisfies MDR without burning your runway. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-investigations-for-software-samd https://zechmeister-solutions.com/en/blog/clinical-investigations-for-software-samd Software medical devices sometimes need clinical investigations and sometimes don't. Here is the decision framework for SaMD startups under MDR. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/alternatives-clinical-investigations https://zechmeister-solutions.com/en/blog/alternatives-clinical-investigations Clinical investigations are not the only MDR evidence source. Alternatives: performance studies, usability data, registries, retrospective analyses. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/bench-testing-non-clinical-evidence-cer https://zechmeister-solutions.com/en/blog/bench-testing-non-clinical-evidence-cer Bench testing and non-clinical evidence can carry large parts of an MDR CER. When Article 61(10) applies and how to stack the pre-clinical package. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/real-world-evidence-mdr-cer https://zechmeister-solutions.com/en/blog/real-world-evidence-mdr-cer Real-world evidence under MDR feeds clinical evaluation through PMCF, registries, surveys, and complaints. Here is how to turn post-market data into a defensible CER. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-consultation-procedure https://zechmeister-solutions.com/en/blog/clinical-evaluation-consultation-procedure CECP under MDR Article 54 sends Class III implantables and certain Class IIb actives to an EU expert panel. Scope, timeline, and CER readiness playbook. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/update-clinical-evaluation-report-lifecycle https://zechmeister-solutions.com/en/blog/update-clinical-evaluation-report-lifecycle The CER is not a one-time document. MDR requires periodic updates driven by PMS and PMCF data. Here is the lifecycle cadence and what triggers an update. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-timelines-startups https://zechmeister-solutions.com/en/blog/clinical-evaluation-timelines-startups Clinical evaluation under MDR takes longer than founders plan. Here are realistic timelines from CEP to CER and the things that break them. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/outsourcing-clinical-evaluation-cro-decision https://zechmeister-solutions.com/en/blog/outsourcing-clinical-evaluation-cro-decision When to hire a CRO for clinical evaluation vs. doing it in-house. Decision matrix, RFP playbook, and what MDR Article 10 still leaves on your desk. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/biggest-clinical-evaluation-mistakes-startups-mdr https://zechmeister-solutions.com/en/blog/biggest-clinical-evaluation-mistakes-startups-mdr The ten clinical evaluation mistakes that appear in almost every MDR startup audit — each anchored to the article they violate and the fix. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-combination-products https://zechmeister-solutions.com/en/blog/clinical-evaluation-combination-products Clinical evaluation for drug-device and biologic-device combination products under MDR: CER scope, ancillary substance data, and the EMA consultation route. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/missing-clinical-data-gap-analysis https://zechmeister-solutions.com/en/blog/missing-clinical-data-gap-analysis A GSPR-by-GSPR gap analysis method for MDR startups whose clinical evaluation comes up short — with four options to close each gap. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/literature-search-protocols-clinical-evaluation https://zechmeister-solutions.com/en/blog/literature-search-protocols-clinical-evaluation A reproducible literature search protocol is a CER prerequisite. Here is how to write one that an auditor can verify and a successor can re-run. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/state-of-the-art-clinical-evaluation https://zechmeister-solutions.com/en/blog/state-of-the-art-clinical-evaluation How to establish state of the art in an MDR clinical evaluation, benchmark alternatives, and demonstrate benefit-risk acceptability under Article 61. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-legacy-devices-mdd-mdr https://zechmeister-solutions.com/en/blog/clinical-evaluation-legacy-devices-mdd-mdr Legacy devices transitioning from MDD to MDR need their clinical evaluations upgraded to MDR Article 61. Here is the gap analysis and how to close it. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/nb-review-clinical-evaluation-reports https://zechmeister-solutions.com/en/blog/nb-review-clinical-evaluation-reports When a Notified Body reviews a CER, they apply a structured checklist. Here is what they check and how to anticipate the review. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evidence-strategy-portfolio https://zechmeister-solutions.com/en/blog/clinical-evidence-strategy-portfolio Plan one clinical evidence strategy across every SKU in your portfolio. Shared pools, family CERs, and PMCF that covers the whole product line. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-post-market-surveillance-mdr https://zechmeister-solutions.com/en/blog/what-is-post-market-surveillance-mdr Post-market surveillance under MDR is the ongoing system for collecting and acting on real-world device data. Here is what Articles 83-86 require and how startups actually build it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-articles-83-86-pms-framework https://zechmeister-solutions.com/en/blog/mdr-articles-83-86-pms-framework MDR Articles 83 to 86 define the post-market surveillance system, plan, report, and PSUR. Here is what each article requires and how they fit together. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-plan-mdr-annex-iii https://zechmeister-solutions.com/en/blog/pms-plan-mdr-annex-iii MDR Annex III defines the contents of a PMS plan. Here is what must appear in it, how to structure it for a startup, and what auditors check. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-report-class-i-devices https://zechmeister-solutions.com/en/blog/pms-report-class-i-devices Class I devices require a PMS report under MDR Article 85. Here is what goes in it and how to keep it current without building infrastructure you do not need. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/psur-class-iia-iib-iii https://zechmeister-solutions.com/en/blog/psur-class-iia-iib-iii The PSUR under MDR Article 86 is the periodic safety update for IIa, IIb, and III devices. Here is the structure, the frequency by class, and what Notified Bodies look for. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-data-sources https://zechmeister-solutions.com/en/blog/pms-data-sources MDR Annex III lists the PMS data sources you must consider. Here is what each one looks like for a startup with limited footprint. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/proactive-vs-reactive-pms https://zechmeister-solutions.com/en/blog/proactive-vs-reactive-pms Reactive PMS waits for complaints. Proactive PMS goes looking for signals. MDR expects both. Here is how to build proactive methods into a startup PMS system. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/customer-complaint-handling-mdr https://zechmeister-solutions.com/en/blog/customer-complaint-handling-mdr Complaint handling is where most PMS systems break down. Here is the process under MDR and ISO 13485 that actually catches safety signals early. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/trend-reporting-mdr-article-88 https://zechmeister-solutions.com/en/blog/trend-reporting-mdr-article-88 MDR Article 88 requires manufacturers to report statistically significant increases in non-serious incidents or expected side-effects. Here is how to detect and report them. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/build-pms-system-startup-budget https://zechmeister-solutions.com/en/blog/build-pms-system-startup-budget A PMS system that runs without burning the team is achievable for a small MedTech company. Here is the lean PMS build that satisfies MDR Annex III. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-samd-monitoring https://zechmeister-solutions.com/en/blog/pms-samd-monitoring Post-market surveillance for SaMD has unique requirements: telemetry, version performance, cybersecurity events. Here is how to design it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-vigilance-mdr https://zechmeister-solutions.com/en/blog/what-is-vigilance-mdr Vigilance under MDR is the mandatory serious-incident reporting system. Here is what it covers, how it differs from PMS, and what startups must report. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-articles-87-92-vigilance-framework https://zechmeister-solutions.com/en/blog/mdr-articles-87-92-vigilance-framework MDR Articles 87 to 92 define the manufacturer vigilance obligations: serious incident reports, trend reports, field safety corrective actions, and the Eudamed flow. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/serious-incidents-mdr https://zechmeister-solutions.com/en/blog/serious-incidents-mdr A serious incident under MDR triggers mandatory reporting. Here is how to determine whether an event meets the threshold — and what to do once it does. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/report-serious-incident-competent-authority https://zechmeister-solutions.com/en/blog/report-serious-incident-competent-authority When a serious incident is reportable, you have 15, 10, or 2 days depending on severity. Here is the step-by-step reporting process. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/vigilance-reporting-timelines-mdr https://zechmeister-solutions.com/en/blog/vigilance-reporting-timelines-mdr MDR Article 87 sets three vigilance deadlines: 15 days for standard serious incidents, 10 days for death or unanticipated deterioration, and 2 days for public health threats. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/field-safety-corrective-actions-fscas-mdr https://zechmeister-solutions.com/en/blog/field-safety-corrective-actions-fscas-mdr A Field Safety Corrective Action under MDR is any manufacturer action taken to reduce risk on a device already on the market. Here is when to trigger one and how to execute it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/field-safety-notices-mdr https://zechmeister-solutions.com/en/blog/field-safety-notices-mdr A Field Safety Notice is how you communicate safety corrective actions to users. MDR Article 2(69) defines it, MDCG 2023-3 Rev.2 shapes it. Here is how to write one. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/recalls-mdr-withdrawing-device-from-market https://zechmeister-solutions.com/en/blog/recalls-mdr-withdrawing-device-from-market A recall under MDR is an FSCA that withdraws a device from use or from the market. Here is the process, the reporting, and how startups should plan for the possibility. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-vigilance-capa-relationship https://zechmeister-solutions.com/en/blog/pms-vigilance-capa-relationship PMS, vigilance, and CAPA are three interlocking MDR processes. Here is how they feed each other and what auditors check for integration. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pmcf-mdr-guide-startups https://zechmeister-solutions.com/en/blog/pmcf-mdr-guide-startups PMCF under MDR is the ongoing collection of clinical data after CE marking. Here is the complete guide: plan, execution, report, and the lifecycle loop. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/write-pmcf-plan-annex-xiv-part-b https://zechmeister-solutions.com/en/blog/write-pmcf-plan-annex-xiv-part-b A PMCF plan under MDR Annex XIV Part B structures your post-market clinical follow-up. Here is what to include and how to keep it proportionate. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/write-pmcf-evaluation-report https://zechmeister-solutions.com/en/blog/write-pmcf-evaluation-report The PMCF evaluation report under MDR Annex XIV Part B summarises post-market clinical data. Here is the structure that satisfies auditors. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pmcf-study-design-prospective https://zechmeister-solutions.com/en/blog/pmcf-study-design-prospective A PMCF study collects post-market clinical data on a CE-marked device. Here is how to design a prospective PMCF study that satisfies MDR Annex XIV Part B. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pmcf-surveys-registries-startups https://zechmeister-solutions.com/en/blog/pmcf-surveys-registries-startups PMCF surveys and registries are low-cost ways to collect post-market clinical data. Here is when each fits and how to design them under MDR Annex XIV Part B. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pmcf-not-required-justification https://zechmeister-solutions.com/en/blog/pmcf-not-required-justification PMCF is not always required under MDR. Here is when you can justify a no-PMCF position and what evidence the Notified Body expects. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pmcf-software-ai-ml-devices https://zechmeister-solutions.com/en/blog/pmcf-software-ai-ml-devices PMCF for software and AI devices looks different from hardware PMCF. Here is how to design continuous performance monitoring that satisfies MDR Annex XIV Part B. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-feedback-risk-management https://zechmeister-solutions.com/en/blog/pms-feedback-risk-management MDR requires PMS data to feed back into the risk file. Here is how the loop works under EN ISO 14971 and what auditors check for integration. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-data-updates-clinical-evaluation https://zechmeister-solutions.com/en/blog/pms-data-updates-clinical-evaluation MDR requires PMS and PMCF data to update the clinical evaluation report on a lifecycle cadence. Here is how the CER-PMS loop actually closes. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-labeling-updates-ifu-changes https://zechmeister-solutions.com/en/blog/pms-labeling-updates-ifu-changes When PMS data shows a new risk, the IFU has to change. Here is how to decide between an IFU update, an FSN, and an FSCA under MDR. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/market-surveillance-competent-authorities https://zechmeister-solutions.com/en/blog/market-surveillance-competent-authorities Competent Authorities perform market surveillance under MDR Articles 93-100. Here is what that means in practice and how startups should be prepared. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/handle-market-surveillance-inspection https://zechmeister-solutions.com/en/blog/handle-market-surveillance-inspection A Competent Authority market surveillance inspection lands differently than an NB audit. Here is how to handle it without making the situation worse. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sscp-mdr-article-32 https://zechmeister-solutions.com/en/blog/sscp-mdr-article-32 SSCP under MDR Article 32 is a public-facing safety and performance summary for implantables and Class III devices. Here is what it must contain and who reads it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/write-sscp-class-iii-implantable https://zechmeister-solutions.com/en/blog/write-sscp-class-iii-implantable Write an SSCP for Class III and implantable devices under MDR Article 32: section-by-section template, lay summary rules, and NB validation steps. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-tools-software-startups https://zechmeister-solutions.com/en/blog/pms-tools-software-startups PMS tools and software for MDR startups: the categories that matter, the build-vs-buy decision, and the lean stack that satisfies Annex III. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/using-ai-pms-automation https://zechmeister-solutions.com/en/blog/using-ai-pms-automation AI can accelerate PMS by automating complaint triage, trend detection, and literature surveillance. Here is how to use it without losing the safety net. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/8-common-pms-mistakes-startups-mdr https://zechmeister-solutions.com/en/blog/8-common-pms-mistakes-startups-mdr The eight most common post-market surveillance mistakes in MDR startup audits — each with the article it violates and how to fix it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-multi-market-coordinating-eu https://zechmeister-solutions.com/en/blog/pms-multi-market-coordinating-eu PMS for a device sold across multiple EU Member States needs coordination across competent authorities. Here is how to design it under MDR. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/demonstrate-continuous-compliance-pms https://zechmeister-solutions.com/en/blog/demonstrate-continuous-compliance-pms Continuous compliance under MDR is demonstrated through PMS records that auditors can trace end to end. Here is how to make it visible. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pms-reporting-checklist-startups https://zechmeister-solutions.com/en/blog/pms-reporting-checklist-startups The complete PMS reporting checklist for MedTech startups: what is due, when it is due, and which article mandates it — by device class. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/technical-documentation-under-mdr https://zechmeister-solutions.com/en/blog/technical-documentation-under-mdr Technical documentation is the evidence file that proves your device meets MDR. Here is what Annex II requires and why most startups build it wrong. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-ii-structure https://zechmeister-solutions.com/en/blog/mdr-annex-ii-structure MDR Annex II lists exactly what the technical documentation must contain, section by section. Here is the structure, the order, and the traps startups fall into. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-iii-pms-technical-documentation https://zechmeister-solutions.com/en/blog/mdr-annex-iii-pms-technical-documentation MDR Annex III is the technical documentation dedicated to post-market surveillance. Here is what it contains, how it relates to Annex II, and how startups build it. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/build-technical-documentation-from-day-one https://zechmeister-solutions.com/en/blog/build-technical-documentation-from-day-one Building technical documentation from day one does not mean Annex II-ready from day one. Here is the phased approach that avoids paralysis without losing traceability. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/device-description-technical-documentation https://zechmeister-solutions.com/en/blog/device-description-technical-documentation The device description is the first section of your MDR technical file. Here is what must appear in it and how to write it once so it survives design changes. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/documenting-intended-purpose-technical-file https://zechmeister-solutions.com/en/blog/documenting-intended-purpose-technical-file Your documented intended purpose drives classification, clinical evaluation, and labeling. Here is how to write it in the technical file so it holds up. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-manufacturing-information-tech-doc https://zechmeister-solutions.com/en/blog/design-manufacturing-information-tech-doc Annex II Section 3 requires design and manufacturing information in the technical file. Here is what belongs in it and how to avoid over-documenting or under-documenting. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/document-gspr-annex-i-checklist https://zechmeister-solutions.com/en/blog/document-gspr-annex-i-checklist The GSPR checklist maps every MDR Annex I requirement to the evidence in your technical file. Here is how to build one auditors will accept. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/benefit-risk-analysis-technical-documentation https://zechmeister-solutions.com/en/blog/benefit-risk-analysis-technical-documentation The benefit-risk analysis is one section of Annex II Section 5 and one of the most scrutinised. Here is how to structure and present it. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/verification-validation-evidence-technical-documentation https://zechmeister-solutions.com/en/blog/verification-validation-evidence-technical-documentation V&V evidence is what proves your device meets its specifications and intended purpose. Here is how to organize it in the technical file so auditors can follow the chain. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pre-clinical-testing-documentation https://zechmeister-solutions.com/en/blog/pre-clinical-testing-documentation Pre-clinical test evidence supports the benefit-risk analysis under MDR. Here is what to document for bench tests and animal studies in your technical file. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/biocompatibility-documentation-mdr https://zechmeister-solutions.com/en/blog/biocompatibility-documentation-mdr Biocompatibility evidence under MDR relies on the ISO 10993 series. Here is the evidence structure, decision pathway, and what auditors look for in the technical file. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/chemical-characterization-technical-documentation https://zechmeister-solutions.com/en/blog/chemical-characterization-technical-documentation Chemical characterization under ISO 10993-18 supports biocompatibility conclusions. Here is what to document for MDR and when full extractables/leachables studies are needed. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sterilization-validation-documentation-mdr https://zechmeister-solutions.com/en/blog/sterilization-validation-documentation-mdr Sterile devices under MDR require validated sterilization processes documented in the technical file. Here is the evidence structure that satisfies Annex I Section 11. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/shelf-life-stability-testing-documentation https://zechmeister-solutions.com/en/blog/shelf-life-stability-testing-documentation Shelf life claims under MDR must be supported by stability testing evidence. Here is what to document for accelerated and real-time studies. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/transport-storage-validation-tech-doc https://zechmeister-solutions.com/en/blog/transport-storage-validation-tech-doc Transport and storage validation evidence under MDR: what to test, what to document, and where it sits in the technical file. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-documentation-technical-file https://zechmeister-solutions.com/en/blog/software-documentation-technical-file MDR Annex II and EN 62304 together define what software documentation must appear in the technical file. Here is the complete document set. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/technical-documentation-lifecycle-update https://zechmeister-solutions.com/en/blog/technical-documentation-lifecycle-update Technical documentation under MDR is a living file, not a one-shot submission. Here is the lifecycle approach that keeps it audit-ready year after year. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/nb-technical-documentation-review-scrutinized https://zechmeister-solutions.com/en/blog/nb-technical-documentation-review-scrutinized When a Notified Body reviews technical documentation, they sample specific sections and trace evidence chains. Here is what they actually check. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/technical-documentation-templates-startups https://zechmeister-solutions.com/en/blog/technical-documentation-templates-startups Templates can speed up MDR technical documentation work or sink it. Here is the right way to use them and how to avoid the Berlin template trap. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/manage-technical-documentation-small-team https://zechmeister-solutions.com/en/blog/manage-technical-documentation-small-team Managing the MDR technical file with a 3-person team is possible if you pick the right structure, tools, and discipline. Here is the practical approach. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/document-control-mdr-version-approval-distribution https://zechmeister-solutions.com/en/blog/document-control-mdr-version-approval-distribution Document control under MDR ties version, approval, and distribution into one auditable chain. Here is how to run it without overhead. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/technical-documentation-class-i-minimum-viable https://zechmeister-solutions.com/en/blog/technical-documentation-class-i-minimum-viable Class I devices still need a technical file under MDR Annex II. Here is the minimum viable version that satisfies self-certification requirements. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/technical-documentation-samd-special https://zechmeister-solutions.com/en/blog/technical-documentation-samd-special SaMD technical documentation has special considerations under MDR Annex II. Here is what differs from physical-device tech files. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cross-reference-technical-file https://zechmeister-solutions.com/en/blog/cross-reference-technical-file Cross-reference your MDR technical file so evidence is traceable in minutes, not days. GSPR-driven matrix, naming conventions, tooling. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-tech-doc-gaps-startup-audits https://zechmeister-solutions.com/en/blog/common-tech-doc-gaps-startup-audits The ten most common technical documentation gaps that surface in startup MDR audits — and the Annex II section each one lives in. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-labeling-requirements https://zechmeister-solutions.com/en/blog/mdr-labeling-requirements MDR Annex I Chapter III Section 23 lists what must appear on a medical device label. Here is the complete list with how it applies to small labels. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-annex-i-chapter-iii-information-supplied https://zechmeister-solutions.com/en/blog/mdr-annex-i-chapter-iii-information-supplied MDR Annex I Chapter III defines the information that must be supplied with every device. Here is the structure of Section 23 and what it requires. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/instructions-for-use-mdr-compliant https://zechmeister-solutions.com/en/blog/instructions-for-use-mdr-compliant The IFU must meet MDR Annex I Chapter III and survive usability engineering. Here is how to write one that auditors accept and users understand. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/when-ifu-not-required-mdr https://zechmeister-solutions.com/en/blog/when-ifu-not-required-mdr Some Class I devices can be placed on the market without paper IFU under MDR Annex I Chapter III. Here is when the exception applies and what still must be communicated. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/electronic-instructions-for-use-eifu-mdr https://zechmeister-solutions.com/en/blog/electronic-instructions-for-use-eifu-mdr When you can replace a paper IFU with an eIFU under MDR and Regulation (EU) 2021/2226: eligible devices, website rules, and paper-on-request. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-symbols-iso-15223-1 https://zechmeister-solutions.com/en/blog/mdr-symbols-iso-15223-1 MDR allows symbols on labels only from a recognised standard. Here is how EN ISO 15223-1:2021 maps to Annex I Chapter III Section 23. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-on-label-display https://zechmeister-solutions.com/en/blog/udi-on-label-display MDR Article 27 requires the UDI to appear on the device label. Here is how to display UDI-DI and UDI-PI correctly. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/implant-cards-mdr https://zechmeister-solutions.com/en/blog/implant-cards-mdr MDR Article 18 requires manufacturers of implantable devices to provide an implant card. Here is what it must contain and how to design one. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/multi-language-labeling-mdr-startups https://zechmeister-solutions.com/en/blog/multi-language-labeling-mdr-startups MDR Article 10(11) sets language for labels, IFU, and patient information per Member State. Here is a practical multi-language approach for startups. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/patient-information-lay-users-mdr https://zechmeister-solutions.com/en/blog/patient-information-lay-users-mdr MDR Annex I Section 23 and Article 32 force patient information into plain language. Here is how to write lay-user content auditors and patients accept. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/promotional-material-mdr-article-7 https://zechmeister-solutions.com/en/blog/promotional-material-mdr-article-7 MDR Article 7 prohibits misleading promotional claims. Here is what promotional material can and cannot say about your medical device. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/misleading-claims-mdr https://zechmeister-solutions.com/en/blog/misleading-claims-mdr MDR Article 7 prohibits misleading claims. Your marketing must stay within the technical documentation and the intended purpose. Here is the compliance line. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/labeling-software-medical-device https://zechmeister-solutions.com/en/blog/labeling-software-medical-device MDR labeling requirements apply to SaMD as much as to physical devices. Here is how to deliver MDR-compliant labels and IFU through a digital interface. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/lot-numbering-traceability-mdr https://zechmeister-solutions.com/en/blog/lot-numbering-traceability-mdr Lot numbering is the production identifier that makes MDR Article 25 traceability and recalls actually work. Here is the startup playbook. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ce-mark-placement-formatting-mdr https://zechmeister-solutions.com/en/blog/ce-mark-placement-formatting-mdr How to place, size, and format the CE mark on medical devices under MDR Article 20 and Annex V — with Notified Body number rules. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-labeling-mistakes-startups-mdr https://zechmeister-solutions.com/en/blog/common-labeling-mistakes-startups-mdr The ten most common labeling mistakes in MedTech startup audits — each with the Annex I Chapter III requirement it violates and the fix. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/tech-doc-labeling-startup-audit-checklist https://zechmeister-solutions.com/en/blog/tech-doc-labeling-startup-audit-checklist The complete pre-audit checklist for MDR technical documentation and labeling: every Annex II section, every Annex I Chapter III label item, every cross-reference. Technical Documentation & Labeling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-eudamed-european-database-medical-devices https://zechmeister-solutions.com/en/blog/what-is-eudamed-european-database-medical-devices EUDAMED is the European database for medical devices. Here is what it is, which modules are live, and what MDR Articles 33-34 require startups to register. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-status-2026 https://zechmeister-solutions.com/en/blog/eudamed-status-2026 EUDAMED module status in early 2026: what is live, what is voluntary, and how the Article 34 mechanism determines when mandatory use kicks in. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/register-startup-manufacturer-eudamed https://zechmeister-solutions.com/en/blog/register-startup-manufacturer-eudamed Manufacturer registration in EUDAMED under MDR Article 31 produces your SRN. Here is the step-by-step process and the data you need ready. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/single-registration-number-srn https://zechmeister-solutions.com/en/blog/single-registration-number-srn The SRN is a one-time identifier for manufacturers, authorised representatives, and importers under MDR. Here is how to obtain one and what it is used for. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/device-registration-eudamed-step-by-step https://zechmeister-solutions.com/en/blog/device-registration-eudamed-step-by-step Registering a device in EUDAMED under MDR Article 29 is a sequence of specific steps. Here is the startup walkthrough with the exact data fields required. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-udi https://zechmeister-solutions.com/en/blog/what-is-udi UDI is the unique device identification system under MDR Articles 27 to 29. Here is what it is, what the components mean, and what startups must do to comply. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-articles-27-29-udi-requirements https://zechmeister-solutions.com/en/blog/mdr-articles-27-29-udi-requirements MDR Articles 27 to 29 define the UDI system, device registration, and manufacturer registration. Here is what each article requires and the sequence startups must follow. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-di-vs-udi-pi https://zechmeister-solutions.com/en/blog/udi-di-vs-udi-pi UDI consists of two parts — UDI-DI (static device identifier) and UDI-PI (production identifier). Here is how they differ and why both matter. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/basic-udi-di-master-identifier https://zechmeister-solutions.com/en/blog/basic-udi-di-master-identifier Basic UDI-DI is the master identifier for a device family under MDR. Here is what it is, how to assign it, and how it differs from UDI-DI. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/obtain-udi-issuing-entity https://zechmeister-solutions.com/en/blog/obtain-udi-issuing-entity The Commission designates four UDI issuing entities: GS1, HIBCC, ICCBBA, and IFA. Here is how to choose the right one and what each costs. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-assignment-samd-special-rules https://zechmeister-solutions.com/en/blog/udi-assignment-samd-special-rules SaMD has specific UDI assignment rules under MDR. Here is when a software change requires a new UDI-DI and how to display the UDI for software. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-database-registration-eudamed https://zechmeister-solutions.com/en/blog/udi-database-registration-eudamed The UDI database inside EUDAMED captures device identification data under MDR Article 28. Here is the data you must enter and how to keep it current. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-carrier-requirements https://zechmeister-solutions.com/en/blog/udi-carrier-requirements MDR requires UDI to appear on the label in both AIDC and human-readable formats. Here is what carriers are accepted and how to choose. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-kits-systems-mdr https://zechmeister-solutions.com/en/blog/udi-kits-systems-mdr Kits and procedure packs need careful UDI handling under MDR. Here is how to assign UDIs to multi-component devices and the kit-level identifier. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-implementation-timeline-by-class https://zechmeister-solutions.com/en/blog/udi-implementation-timeline-by-class UDI obligations under MDR phase in by device class. Here is the implementation timeline and what is already in force in 2026. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-certificates-module https://zechmeister-solutions.com/en/blog/eudamed-certificates-module The EUDAMED certificates module makes Notified Body certificates publicly visible. Here is what it captures and what manufacturers should know. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-vigilance-module https://zechmeister-solutions.com/en/blog/eudamed-vigilance-module The EUDAMED vigilance module is where serious incidents and FSCAs flow under MDR Article 87. Here is what it captures and how to report. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-clinical-investigation-module https://zechmeister-solutions.com/en/blog/eudamed-clinical-investigation-module The EUDAMED clinical investigation module registers studies, sponsors, and outcomes. Here is what it requires and when the obligation applies. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-market-surveillance-module https://zechmeister-solutions.com/en/blog/eudamed-market-surveillance-module The EUDAMED market surveillance module aggregates what Competent Authorities see about your device. Here is what it captures and what that means for manufacturers. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-transparency-startup-strategy https://zechmeister-solutions.com/en/blog/eudamed-transparency-startup-strategy EUDAMED transparency means competitors can read your SSCP, certificates and vigilance summaries. Here is how to plan your startup strategy around it. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-sscp-public-access https://zechmeister-solutions.com/en/blog/eudamed-sscp-public-access How the SSCP reaches EUDAMED: Article 32 publication duty, Notified Body validation gate, languages, and the public access flow for clinicians and patients. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/national-registration-eu-member-states https://zechmeister-solutions.com/en/blog/national-registration-eu-member-states EUDAMED is not a one-stop register. National registration duties continue in France, Germany, Italy, Belgium and more. Here is what still applies. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/dmids-germany-medical-device-information-system https://zechmeister-solutions.com/en/blog/dmids-germany-medical-device-information-system DMIDS is Germany's national medical device information system under the MPDG. How it relates to EUDAMED and what startups selling in Germany must do. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/bfarm-registration-germany https://zechmeister-solutions.com/en/blog/bfarm-registration-germany Germany registers medical devices through BfArM via the DMIDS portal alongside EUDAMED. Here is how the German national layer actually works under MDR. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ansm-registration-france https://zechmeister-solutions.com/en/blog/ansm-registration-france France requires manufacturers to notify the ANSM for certain devices alongside EUDAMED. Here is how the French national registration works at general framing. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/basg-ages-registration-austria https://zechmeister-solutions.com/en/blog/basg-ages-registration-austria Austria's BASG, operated through AGES, verifies MDR Article 31 data and runs national device duties. Here is how Austrian registration works. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-multi-market-management https://zechmeister-solutions.com/en/blog/udi-multi-market-management Manage UDI across EU MDR and FDA with one identifier strategy. Issuing entities, UDI-DI vs UDI-PI mapping, and a one-label-many-markets playbook. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/udi-cost-implementation-effort-startups https://zechmeister-solutions.com/en/blog/udi-cost-implementation-effort-startups UDI compliance has both fixed and recurring costs. Here are honest estimates of effort and cost for a MedTech startup at general framing. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/5-common-udi-mistakes-startups-mdr https://zechmeister-solutions.com/en/blog/5-common-udi-mistakes-startups-mdr The five UDI mistakes that show up in almost every MedTech startup audit, with the article each one violates and the fix. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eudamed-udi-compliance-checklist https://zechmeister-solutions.com/en/blog/eudamed-udi-compliance-checklist The complete EUDAMED and UDI compliance checklist for MedTech startups — SRN, actor registration, Basic UDI-DI, UDI-DI, database entry, and label carrier. EUDAMED, UDI & Registration office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-quality-management-system-medical-devices https://zechmeister-solutions.com/en/blog/what-is-quality-management-system-medical-devices A medical device QMS is how you systematically ensure MDR compliance. Here is what Article 10(9) requires and how EN ISO 13485:2016 helps you meet it. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-qms-requirements-iso-13485-conformity https://zechmeister-solutions.com/en/blog/mdr-qms-requirements-iso-13485-conformity MDR Article 10(9) requires a QMS. EN ISO 13485:2016+A11:2021 provides presumption of conformity. Here is exactly how the standard discharges the requirement. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-article-10-9-annex-ix-qms-requirements https://zechmeister-solutions.com/en/blog/mdr-article-10-9-annex-ix-qms-requirements MDR Article 10(9) mandates a QMS. Annex IX defines how a Notified Body assesses it. Here is what both require and how they connect to EN ISO 13485. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iso-13485-vs-iso-9001 https://zechmeister-solutions.com/en/blog/iso-13485-vs-iso-9001 ISO 9001 is a general quality management standard. ISO 13485 is medical device-specific. Here is why MDR effectively requires the latter, and what the differences actually are. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/build-lean-qms-mdr-startup https://zechmeister-solutions.com/en/blog/build-lean-qms-mdr-startup A lean QMS is not a stripped-down QMS. It is a QMS where every process reflects real work and nothing else. Here is how startups build one that actually runs. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/minimum-viable-qms https://zechmeister-solutions.com/en/blog/minimum-viable-qms The minimum viable QMS is the smallest QMS that satisfies MDR Article 10(9) and EN ISO 13485:2016+A11:2021 for your specific device. Here is what you need before your first audit. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qms-process-approach-startups https://zechmeister-solutions.com/en/blog/qms-process-approach-startups The process approach is the foundation of EN ISO 13485. Here is how to map a startup's real processes into a QMS that auditors recognize as a working system. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/quality-policy-objectives-startup https://zechmeister-solutions.com/en/blog/quality-policy-objectives-startup EN ISO 13485 clauses 5.3 and 5.4 require a quality policy and quality objectives. Here is how to write them for a startup without sounding like a corporate template. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/management-responsibility-mdr https://zechmeister-solutions.com/en/blog/management-responsibility-mdr Top management under MDR is accountable for the QMS. Here is what the CEO or founder must personally own, using EN ISO 13485 clause 5 as the framework. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-qms-management-review-startup https://zechmeister-solutions.com/en/blog/mdr-qms-management-review-startup Management review under ISO 13485 clause 5.6 is where the CEO signs off on the QMS. Here is how to run it efficiently in a small team without turning it into theatre. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/resource-management-mdr-iso-13485 https://zechmeister-solutions.com/en/blog/resource-management-mdr-iso-13485 EN ISO 13485 clause 6 covers personnel, infrastructure, and work environment for medical device manufacturers. Here is how to apply it in a startup. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-competence-requirements-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-competence-requirements-iso-13485 EN ISO 13485 clause 6.2 requires documented competence for personnel performing work affecting product quality. Here is how startups operate it. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/document-control-startup https://zechmeister-solutions.com/en/blog/document-control-startup Document control is where most small-team QMS systems break. Here is an ISO 13485 clause 4.2.4-based approach that actually works for MedTech startups. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/record-control-mdr https://zechmeister-solutions.com/en/blog/record-control-mdr Records under EN ISO 13485 clause 4.2.5 must be identifiable, retrievable, legible, and retained for defined periods. Here is what that means for a startup. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-development-planning https://zechmeister-solutions.com/en/blog/mdr-design-development-planning EN ISO 13485 clause 7.3.2 requires design and development planning. Here is what to include and how to keep it proportionate in a startup. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-input-requirements-medtech https://zechmeister-solutions.com/en/blog/design-input-requirements-medtech Design inputs are the specifications that define what the device must do. EN ISO 13485 clause 7.3.3 expects them to be unambiguous and verifiable. Here is how to write them. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-output-requirements-medtech https://zechmeister-solutions.com/en/blog/design-output-requirements-medtech Design outputs are the specifications produced by development: drawings, code, parameters. EN ISO 13485 clause 7.3.4 defines what they must show. Here is how to document them. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-reviews-iso-13485-startup https://zechmeister-solutions.com/en/blog/mdr-design-reviews-iso-13485-startup Design reviews under ISO 13485 clause 7.3.5 are more than meetings. Here is how to run them effectively in a startup without making them theatre. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-verification-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-design-verification-iso-13485 Design verification under ISO 13485 clause 7.3.6 proves that design outputs meet design inputs. Here is what that looks like in practice and how to document it. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-validation-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-design-validation-iso-13485 Design validation under ISO 13485 clause 7.3.7 proves the finished device meets the user needs and intended use. Here is what validation evidence looks like for a startup. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-transfer https://zechmeister-solutions.com/en/blog/mdr-design-transfer Design transfer under EN ISO 13485 clause 7.3.8 moves a validated design into production. Here is what the clause requires and how startups handle the handoff. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-design-changes-iterations https://zechmeister-solutions.com/en/blog/mdr-design-changes-iterations Design changes are constant in MedTech development. EN ISO 13485 clause 7.3.9 defines how to manage them. Here is how to iterate without breaking compliance. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-history-file-mdr https://zechmeister-solutions.com/en/blog/design-history-file-mdr The Design History File documents your medical device development story. MDR does not use the term but ISO 13485 clause 7.3 requires exactly this. Here is how to build one. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/dmr-dhr-traceability-records https://zechmeister-solutions.com/en/blog/dmr-dhr-traceability-records DMR and DHR are FDA terms. Under MDR, the medical device file in ISO 13485 clause 4.2.3 and production records in clause 7.5 do the same job. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-supplier-control-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-supplier-control-iso-13485 Supplier control is where many MDR audits surface findings. EN ISO 13485 clause 7.4 defines the expectation. Here is the startup-scale implementation. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/supplier-qualification-mdr-iso-13485 https://zechmeister-solutions.com/en/blog/supplier-qualification-mdr-iso-13485 EN ISO 13485 clause 7.4.1 requires supplier qualification proportionate to product impact. Here is the startup-scale qualification process. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/outsourced-processes-contract-manufacturers https://zechmeister-solutions.com/en/blog/outsourced-processes-contract-manufacturers How MDR and EN ISO 13485 treat outsourced processes and contract manufacturers, with a quality agreement playbook for lean MedTech startups. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/production-controls-iso-13485-7-5 https://zechmeister-solutions.com/en/blog/production-controls-iso-13485-7-5 Walk MDR production controls clause by clause through EN ISO 13485 section 7.5, with a lean production control playbook for MedTech startups. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/process-validation-mdr-iso-13485 https://zechmeister-solutions.com/en/blog/process-validation-mdr-iso-13485 EN ISO 13485 clause 7.5.6 requires validation of processes whose output cannot be fully verified. Here is what that means in practice. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-traceability-requirements https://zechmeister-solutions.com/en/blog/mdr-traceability-requirements MDR requires traceability of devices from production to end user. EN ISO 13485 clauses 7.5.8 and 7.5.9 provide the framework. Here is the startup implementation. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/monitoring-measuring-equipment-control https://zechmeister-solutions.com/en/blog/monitoring-measuring-equipment-control How EN ISO 13485 clause 7.6 governs calibration, traceability, and software validation for monitoring and measuring equipment under MDR. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/capa-mdr-iso-13485 https://zechmeister-solutions.com/en/blog/capa-mdr-iso-13485 CAPA under MDR relies on EN ISO 13485 clauses 8.5.2 and 8.5.3. Here is the full process from nonconformity detection to effectiveness verification. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/capa-without-bureaucratic-overhead https://zechmeister-solutions.com/en/blog/capa-without-bureaucratic-overhead A good CAPA process finds real root causes and prevents recurrence. A bad one generates paperwork. Here is how to run the effective kind in a small team. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/root-cause-analysis-medtech-startups https://zechmeister-solutions.com/en/blog/root-cause-analysis-medtech-startups Root cause analysis is the heart of CAPA under EN ISO 13485. Here are the techniques that work in small MedTech teams without bureaucratic overhead. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/nonconforming-product-control https://zechmeister-solutions.com/en/blog/nonconforming-product-control How nonconforming product control MDR ISO 13485 clause 8.3 segregation, decision records, and the bridge to FSCA and vigilance actually work. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/internal-audits-startup https://zechmeister-solutions.com/en/blog/internal-audits-startup Internal audits under ISO 13485 are mandatory and independent. Here is how a 3-person startup actually runs them without faking independence or drowning in paperwork. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/internal-audits-3-person-team https://zechmeister-solutions.com/en/blog/internal-audits-3-person-team Internal audits are mandatory under EN ISO 13485 even for the smallest teams. Here is how a 3-person MedTech startup runs them without breaking independence. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-customer-feedback-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-customer-feedback-iso-13485 EN ISO 13485 clause 8.2.2 requires a documented procedure for customer feedback. Here is how it ties to MDR PMS, vigilance, and CAPA. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/continual-improvement-mdr-iso-13485 https://zechmeister-solutions.com/en/blog/continual-improvement-mdr-iso-13485 EN ISO 13485 clauses 8.4 and 8.5.1 require data analysis and continual improvement. Here is how to operate them in a startup without theatre. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eqms-platforms-startups-2026 https://zechmeister-solutions.com/en/blog/eqms-platforms-startups-2026 How to compare eQMS platforms for a MedTech startup under MDR — what the tool must support, build vs buy, and a neutral selection playbook. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cloud-based-qms-tools-mdr https://zechmeister-solutions.com/en/blog/cloud-based-qms-tools-mdr Cloud-based eQMS platforms are attractive for startups, but they bring specific MDR compliance considerations. Here is what to check before committing. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-qms-software-companies-agile https://zechmeister-solutions.com/en/blog/mdr-qms-software-companies-agile How to build an EN ISO 13485:2016+A11:2021 QMS for a software-first MedTech startup that runs agile sprints, without burning runway on paper. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/agile-sprints-iso-13485-design-controls https://zechmeister-solutions.com/en/blog/agile-sprints-iso-13485-design-controls ISO 13485 design controls can coexist with agile sprints if the design record is captured at the right cadence. Here is how. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qms-documentation-templates-startups https://zechmeister-solutions.com/en/blog/qms-documentation-templates-startups The essential QMS documentation templates startups need for MDR: the document list mapped to Article 10(9) and EN ISO 13485:2016+A11:2021 clause 4.2. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-qms-certification-iso-13485 https://zechmeister-solutions.com/en/blog/mdr-qms-certification-iso-13485 ISO 13485 certification is how you demonstrate the QMS that MDR Article 10(9) requires. Here is the path from application to certificate. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iso-13485-certification-body-choice https://zechmeister-solutions.com/en/blog/iso-13485-certification-body-choice An ISO 13485 certification body is not the same as an MDR Notified Body. Here is how to choose one that actually serves your MDR path. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-qms-compliance-costs https://zechmeister-solutions.com/en/blog/mdr-qms-compliance-costs ISO 13485 certification costs both fixed fees and ongoing effort. Here is the honest startup cost picture at general framing. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/combine-iso-13485-mdr-annex-ix-audits https://zechmeister-solutions.com/en/blog/combine-iso-13485-mdr-annex-ix-audits How to combine ISO 13485 and MDR Annex IX audits into one efficient assessment, what overlaps, and the gap items only MDR covers. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdsap-startup-decision https://zechmeister-solutions.com/en/blog/mdsap-startup-decision MDSAP startup decision guide: what the single audit covers, the five member markets, and how it relates to ISO 13485 and MDR conformity. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qms-multi-site-remote-teams https://zechmeister-solutions.com/en/blog/qms-multi-site-remote-teams Remote and multi-site MedTech startups face specific QMS challenges. Here is how to keep one QMS coherent across distributed teams. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-qms-audit-nonconformities https://zechmeister-solutions.com/en/blog/common-qms-audit-nonconformities The ten most common QMS audit nonconformities in MDR startup audits — and the ISO 13485 clause each one violates. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/startup-chaos-to-compliant-qms https://zechmeister-solutions.com/en/blog/startup-chaos-to-compliant-qms Most MedTech startups have years of chaos before they need a QMS. Here is the phased approach that converts the mess into compliance without starting from zero. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/maintain-qms-after-certification https://zechmeister-solutions.com/en/blog/maintain-qms-after-certification Certification is the start, not the finish line. Here is the rhythm that keeps a MedTech QMS alive after the first MDR audit without drowning the team. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qms-maturity-model-startups https://zechmeister-solutions.com/en/blog/qms-maturity-model-startups A five-level QMS maturity model for MDR startups — from minimum compliant to strategic excellence, tied back to EN ISO 13485:2016+A11:2021 clauses. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qms-audit-preparation-checklist https://zechmeister-solutions.com/en/blog/qms-audit-preparation-checklist The complete QMS audit preparation checklist for MedTech startups: every document, every process owner, every rehearsal step before the auditor walks in. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/what-is-software-as-medical-device-samd-mdr https://zechmeister-solutions.com/en/blog/what-is-software-as-medical-device-samd-mdr Software is a medical device when its intended purpose meets MDR Article 2(1). Here is how SaMD qualification works and why Rule 11 pushes most software to Class IIa or higher. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/samd-vs-simd-distinction https://zechmeister-solutions.com/en/blog/samd-vs-simd-distinction SaMD is standalone software that is itself a medical device. SiMD drives a hardware device. The distinction changes classification and lifecycle. Here is how to tell them apart. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/when-does-software-qualify-medical-device https://zechmeister-solutions.com/en/blog/when-does-software-qualify-medical-device MDR Article 2(1) and MDCG 2019-11 Rev.1 together answer when software qualifies as a medical device. Here is the decision flowchart in plain text. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdcg-2019-11-software-guidance https://zechmeister-solutions.com/en/blog/mdcg-2019-11-software-guidance MDCG 2019-11 Rev.1 is the definitive EU guidance on when software is a medical device and how to classify it. Here are the key takeaways for startups. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mobile-apps-medical-devices-mdr https://zechmeister-solutions.com/en/blog/mobile-apps-medical-devices-mdr Not every health app is a medical device — but the line under MDR is sharper than founders realise. Here is when your mobile app needs CE marking. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-software-lifecycle-iec-62304 https://zechmeister-solutions.com/en/blog/mdr-software-lifecycle-iec-62304 MDR Annex I Section 17 requires software to be developed under a lifecycle process. EN 62304:2006+A1:2015 is the harmonised standard that gets you there. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-safety-classification-iec-62304 https://zechmeister-solutions.com/en/blog/software-safety-classification-iec-62304 EN 62304 classifies software by safety impact — Class A (no injury), B (non-serious injury), C (death or serious injury possible). Here is how the class drives what you must do. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-safety-class-drives-effort https://zechmeister-solutions.com/en/blog/software-safety-class-drives-effort EN 62304 scales activities by software safety class. Here is what changes between A, B, and C and how much effort each level actually requires. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-development-planning-iec-62304 https://zechmeister-solutions.com/en/blog/software-development-planning-iec-62304 EN 62304 Section 5.1 requires a software development plan. Here is what must be in it, how to keep it proportionate, and the startup-scale version. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-requirements-iec-62304 https://zechmeister-solutions.com/en/blog/software-requirements-iec-62304 EN 62304 Section 5.2 requires software requirements analysis and documentation. Here is how to write software requirements that satisfy both MDR and the standard. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-architecture-documentation-iec-62304 https://zechmeister-solutions.com/en/blog/software-architecture-documentation-iec-62304 EN 62304 Section 5.3 requires software architecture documentation. Here is what it must contain, how SOUP is flagged, and how startups keep it lean. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-detailed-design-iec-62304-when https://zechmeister-solutions.com/en/blog/software-detailed-design-iec-62304-when EN 62304 Section 5.4 detailed design is required for Class B and C software only. Here is how much depth each class needs and when Class A can skip. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-detailed-design-iec-62304 https://zechmeister-solutions.com/en/blog/software-detailed-design-iec-62304 EN 62304 Section 5.4 requires detailed design for Class B and C software units. Here is what to document and when to skip it. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-verification-unit-testing-iec-62304 https://zechmeister-solutions.com/en/blog/software-verification-unit-testing-iec-62304 EN 62304 Section 5.5 defines software unit verification. Here is what unit testing requires for medical software at each safety class. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-integration-testing-iec-62304 https://zechmeister-solutions.com/en/blog/software-integration-testing-iec-62304 EN 62304 Section 5.6 defines software integration and integration testing. Here is how to scope, run, and document it for MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-system-testing-iec-62304 https://zechmeister-solutions.com/en/blog/software-system-testing-iec-62304 System testing under EN 62304 Section 5.7 verifies software against its system requirements. Here is how to scope, execute, and document it. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-release-process-iec-62304 https://zechmeister-solutions.com/en/blog/software-release-process-iec-62304 How to run a compliant medical software release under EN 62304 clause 5.8 and MDR Annex II, with a worked example and a startup release playbook. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-software-maintenance-iec-62304 https://zechmeister-solutions.com/en/blog/mdr-software-maintenance-iec-62304 EN 62304 clause 6 defines the software maintenance process: bug fixes, updates, problem analysis. Here is how to run it under MDR without re-doing the whole lifecycle. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-software-configuration-management https://zechmeister-solutions.com/en/blog/mdr-software-configuration-management EN 62304 clause 8 defines software configuration management: identification, change control, status accounting. Here is how startups apply it without overhead. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-problem-resolution-iec-62304 https://zechmeister-solutions.com/en/blog/software-problem-resolution-iec-62304 EN 62304 clause 9 defines software problem resolution: prepare, investigate, advise, change control, record, trend. Here is the startup playbook. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/soup-ots-software-mdr https://zechmeister-solutions.com/en/blog/soup-ots-software-mdr SOUP (Software of Unknown Provenance) and OTS components are in almost every medical software stack. EN 62304 defines how to qualify and control them under MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/evaluate-document-soup-ots-components https://zechmeister-solutions.com/en/blog/evaluate-document-soup-ots-components SOUP and OTS components require structured evaluation under EN 62304. Here is the evaluation and documentation method that satisfies MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/open-source-software-medical-devices https://zechmeister-solutions.com/en/blog/open-source-software-medical-devices How open source software medical devices MDR IEC 62304 SOUP rules, SBOM, licensing, and cybersecurity fit together for compliant SaMD. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cloud-services-medical-devices-mdr https://zechmeister-solutions.com/en/blog/cloud-services-medical-devices-mdr Running a medical device on cloud infrastructure brings lifecycle, cybersecurity, and data protection obligations. Here is what MDR requires for cloud-hosted medical software. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/saas-medical-devices-mdr https://zechmeister-solutions.com/en/blog/saas-medical-devices-mdr A medical device delivered as SaaS changes release cadence, PMS, and change control. Here is how MDR applies to multi-tenant SaaS medical software. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-82304-1-complements-iec-62304-samd https://zechmeister-solutions.com/en/blog/iec-82304-1-complements-iec-62304-samd IEC 82304-1 covers health software product safety, complementing IEC 62304's process standard. Here is how the two fit together for SaMD startups. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/agile-development-mdr-iec-62304 https://zechmeister-solutions.com/en/blog/agile-development-mdr-iec-62304 Agile development and EN 62304 can coexist. Here is how to map sprints, releases, and design controls so MDR audit holds. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/devops-medical-software-mdr https://zechmeister-solutions.com/en/blog/devops-medical-software-mdr CI/CD can coexist with EN 62304 if the pipeline captures the right evidence at each stage. Here is the DevOps pattern that satisfies MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-validation-vs-verification-samd https://zechmeister-solutions.com/en/blog/software-validation-vs-verification-samd Verification asks did we build the software right. Validation asks did we build the right software. Here is how the two split for SaMD under MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/csv-manufacturing-software-medical-device https://zechmeister-solutions.com/en/blog/csv-manufacturing-software-medical-device Computer System Validation under EN ISO 13485:2016+A11:2021 clauses 4.1.6 and 7.5.6. Risk-based CSV for startups, with a label printer worked example. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/validating-qms-software-tools-mdr https://zechmeister-solutions.com/en/blog/validating-qms-software-tools-mdr How to validate eQMS, document control, training, and CAPA tools under EN ISO 13485 clause 4.1.6 — risk-based, proportionate, audit-ready. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-62304-amendment-1-2015-changes https://zechmeister-solutions.com/en/blog/iec-62304-amendment-1-2015-changes IEC 62304 Amendment 1 (2015) added legacy software rules, refined problem resolution, and clarified security. Here is what changed and why it matters for MDR. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-traceability-requirements-design-tests-risks https://zechmeister-solutions.com/en/blog/software-traceability-requirements-design-tests-risks The 4-way traceability matrix under EN 62304 and EN ISO 14971 — linking requirements, architecture, tests, and risk controls. With a startup playbook. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/sbom-medical-devices-mdr https://zechmeister-solutions.com/en/blog/sbom-medical-devices-mdr An SBOM is now a baseline expectation for MDR cybersecurity. Here is what to include, which format to pick, and how to keep it alive. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-test-strategy-iec-62304 https://zechmeister-solutions.com/en/blog/software-test-strategy-iec-62304 How to write a software test strategy that satisfies EN 62304 clauses 5.5, 5.6, and 5.7 without drowning a small team in documentation. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/automated-testing-medical-software https://zechmeister-solutions.com/en/blog/automated-testing-medical-software CI/CD for medical software is compatible with EN 62304 if you qualify tools under ISO 13485 clause 4.1.6 and capture evidence as records. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regression-testing-medical-software https://zechmeister-solutions.com/en/blog/regression-testing-medical-software Regression testing medical software MDR: how to scope, select, and evidence regression runs under EN 62304 so updates do not break compliance. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/code-review-practices-mdr https://zechmeister-solutions.com/en/blog/code-review-practices-mdr Code review medical software IEC 62304: what EN 62304 clause 5.5 actually requires, how to record peer reviews, and how to make PR workflow audit-ready. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/static-code-analysis-medical-software https://zechmeister-solutions.com/en/blog/static-code-analysis-medical-software Static code analysis medical software MDR: how SAST fits EN 62304 verification, how to pick rule sets, triage false positives, and capture evidence. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-anomaly-management https://zechmeister-solutions.com/en/blog/software-anomaly-management EN 62304 lets you release medical software with known anomalies if they are documented and risk-evaluated. Here is how to handle them. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-updates-mdr-new-conformity-assessment https://zechmeister-solutions.com/en/blog/software-updates-mdr-new-conformity-assessment Not every software update under MDR requires a new conformity assessment. Here is how to decide whether your update is significant under Annex IX. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/significant-change-software-mdr https://zechmeister-solutions.com/en/blog/significant-change-software-mdr Not every software update is a significant change under MDR. Here is the evaluation framework that decides whether your update needs NB notification. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-documentation-package-iec-62304 https://zechmeister-solutions.com/en/blog/software-documentation-package-iec-62304 The complete IEC 62304 software documentation package for MDR conformity: every artefact, every clause, and what each document must contain. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-requirements-specification-mdr https://zechmeister-solutions.com/en/blog/software-requirements-specification-mdr How to write a software requirements specification for MDR conformity using EN 62304 clause 5.2: the six requirement types, quality rules, and traceability. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-architecture-document-iec-62304 https://zechmeister-solutions.com/en/blog/software-architecture-document-iec-62304 An audit-ready software architecture document under EN 62304 clause 5.3: decomposition, SOUP, segregation of safety items, and the diagrams auditors expect. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/software-test-documentation-iec-62304 https://zechmeister-solutions.com/en/blog/software-test-documentation-iec-62304 How to write software test protocols and reports under EN 62304 clauses 5.5-5.7 that survive an MDR notified body review. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/samd-complete-regulatory-path-startups-2026 https://zechmeister-solutions.com/en/blog/samd-complete-regulatory-path-startups-2026 The complete regulatory path for a Software as a Medical Device startup in 2026: from intended purpose to CE mark, with every standard and article in sequence. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/samd-pre-certification-strategies https://zechmeister-solutions.com/en/blog/samd-pre-certification-strategies Pre-certification strategies for SaMD startups under MDR: parallel R&D and regulatory build, what to lock, what to defer, when to engage a notified body. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/interoperability-medical-software-mdr https://zechmeister-solutions.com/en/blog/interoperability-medical-software-mdr How MDR Annex I §14.2(d) and §17.1 shape interoperability obligations for medical software, and how to verify interfaces like HL7, FHIR, and DICOM. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/api-design-medical-devices-mdr https://zechmeister-solutions.com/en/blog/api-design-medical-devices-mdr How API design for medical devices under MDR creates a regulated boundary, affects intended purpose, and triggers change control and manufacturer liability. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/legacy-software-mdr-compliance https://zechmeister-solutions.com/en/blog/legacy-software-mdr-compliance Legacy software under MDR can be brought into compliance using the Section 8 legacy path. Here is the process for retroactive documentation. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/wearable-medical-devices-mdr https://zechmeister-solutions.com/en/blog/wearable-medical-devices-mdr Wearables span hardware electrical safety, embedded software, and mobile companion app rules. Here is the MDR-compliant approach for wearables. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medical-software-dev-environment-compliance https://zechmeister-solutions.com/en/blog/medical-software-dev-environment-compliance Set up a medical software development environment that satisfies EN 62304 and EN ISO 13485 clause 4.1.6 — source control, CI, tickets, tool validation. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-software-audit-findings-iec-62304 https://zechmeister-solutions.com/en/blog/mdr-software-audit-findings-iec-62304 The 10 most common MDR software audit findings against EN 62304 — from missing problem-resolution records to broken traceability — and how to fix each. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-software-compliance-checklist-startups https://zechmeister-solutions.com/en/blog/mdr-software-compliance-checklist-startups The complete MDR software compliance checklist for MedTech startups — from Rule 11 classification through release, using EN 62304 and the related standards. Software as a Medical Device office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-medical-devices-mdr-regulatory-landscape https://zechmeister-solutions.com/en/blog/ai-medical-devices-mdr-regulatory-landscape AI in medical devices sits at the intersection of MDR and the EU AI Act. Here is the 2026 landscape and how startups should think about the overlap. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/machine-learning-medical-devices-mdr https://zechmeister-solutions.com/en/blog/machine-learning-medical-devices-mdr How MDR Rule 11, intended purpose, and significant-change rules apply to machine learning medical devices and adaptive algorithms. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eu-ai-act-and-mdr https://zechmeister-solutions.com/en/blog/eu-ai-act-and-mdr The EU AI Act layers on top of the MDR for AI medical devices. Here is how the two regulations interact — and what startups need to know about the overlap. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-act-vs-mdr-classification https://zechmeister-solutions.com/en/blog/ai-act-vs-mdr-classification How AI Act risk classification and MDR device classification interact for medical AI, where they overlap, and what dual classification means. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/high-risk-ai-systems-act-medtech https://zechmeister-solutions.com/en/blog/high-risk-ai-systems-act-medtech Extra obligations for high-risk AI in MedTech under the EU AI Act and how to fold them into an existing MDR technical file. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/classification-ai-ml-software-rule-11 https://zechmeister-solutions.com/en/blog/classification-ai-ml-software-rule-11 AI and ML medical software is classified under the same Rule 11 as any other SaMD. Here is how the rule applies to AI specifically. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-decision-support-mdr https://zechmeister-solutions.com/en/blog/clinical-decision-support-mdr Clinical decision support software is sometimes a medical device under MDR and sometimes not. Here is the qualification line and what it depends on. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/locked-vs-adaptive-ai-algorithms-mdr https://zechmeister-solutions.com/en/blog/locked-vs-adaptive-ai-algorithms-mdr Locked AI algorithms behave the same after release. Adaptive algorithms change over time. Under MDR, the regulatory implications are very different. Here is the full picture. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/continuous-learning-ai-mdr-2026 https://zechmeister-solutions.com/en/blog/continuous-learning-ai-mdr-2026 Continuously learning AI sits at the edge of what MDR can currently govern. Here is where the challenge is unsolved in 2026 and how startups should think about it. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdcg-guidance-ai-ml-medical-devices https://zechmeister-solutions.com/en/blog/mdcg-guidance-ai-ml-medical-devices MDCG guidance for AI/ML medical devices is mostly carried by MDCG 2019-11 Rev.1 on software qualification and classification. Here is what it says. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/imdrf-ai-ml-samd-eu https://zechmeister-solutions.com/en/blog/imdrf-ai-ml-samd-eu IMDRF AI/ML SaMD documents are informational, not EU law. Here is exactly how to map them into your MDR file without overreach. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/training-data-requirements-ai-medical-devices https://zechmeister-solutions.com/en/blog/training-data-requirements-ai-medical-devices Training data for AI medical devices must be representative, documented, and controlled. Here is what MDR and MDCG guidance expect — and what auditors check. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/data-quality-bias-ai-medical-devices https://zechmeister-solutions.com/en/blog/data-quality-bias-ai-medical-devices Data quality and bias are core regulatory concerns for AI medical devices. Here is what MDR auditors expect for dataset characterisation and bias testing. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/algorithmic-transparency-mdr https://zechmeister-solutions.com/en/blog/algorithmic-transparency-mdr What algorithmic transparency MDR obligations actually require: intended purpose, residual risks, performance data, and what you may protect. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/explainability-ai-medical-devices https://zechmeister-solutions.com/en/blog/explainability-ai-medical-devices Explainability AI medical devices MDR: there is no specific clause. Here is what notified bodies actually ask for and how to satisfy them honestly. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/clinical-evaluation-ai-ml-medical-devices https://zechmeister-solutions.com/en/blog/clinical-evaluation-ai-ml-medical-devices AI/ML medical devices need clinical evidence plus performance validation, bias testing, and drift monitoring. Here is how to build the clinical evaluation for an AI device. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/performance-validation-ai-medical-devices https://zechmeister-solutions.com/en/blog/performance-validation-ai-medical-devices How to validate AI medical device performance under MDR: the metrics, dataset hygiene, and study designs that hold up in a Notified Body review. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/post-market-surveillance-ai-devices https://zechmeister-solutions.com/en/blog/post-market-surveillance-ai-devices AI medical devices need PMS that monitors algorithm performance, not just complaints. Here is how to build a PMS system with drift detection and performance monitoring. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/drift-detection-ai-medical-devices-mdr https://zechmeister-solutions.com/en/blog/drift-detection-ai-medical-devices-mdr Concept and data drift can degrade AI medical device performance silently. Here are regulatory-aligned drift detection strategies under MDR. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/risk-management-ai-medical-devices https://zechmeister-solutions.com/en/blog/risk-management-ai-medical-devices How to fold AI-specific failure modes — drift, bias, adversarial input, data shift — into an EN ISO 14971 risk management file under MDR. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-ml-change-management-retraining-assessment https://zechmeister-solutions.com/en/blog/ai-ml-change-management-retraining-assessment When retraining an AI/ML medical device counts as a significant change, it can trigger a new conformity assessment. Here is how to decide. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pccp-ai-medical-devices https://zechmeister-solutions.com/en/blog/pccp-ai-medical-devices PCCP is FDA terminology. Here is how to build an equivalent change control plan for AI medical devices under the MDR significant change framework. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/generative-ai-medtech-mdr https://zechmeister-solutions.com/en/blog/generative-ai-medtech-mdr When a generative AI or LLM tool becomes a medical device under MDR, why hallucination is a safety hazard, and how intended purpose decides everything. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/computer-aided-detection-cade-mdr https://zechmeister-solutions.com/en/blog/computer-aided-detection-cade-mdr Computer-Aided Detection software flags potential findings for clinician review. Here is how MDR classifies CADe and what it requires. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cadx-mdr-higher-risk https://zechmeister-solutions.com/en/blog/cadx-mdr-higher-risk CADx software under MDR sits at Class IIb or higher under Rule 11. Why the evidence bar and notified body scrutiny are stricter than for CADe. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-imaging-analysis-radiology-mdr https://zechmeister-solutions.com/en/blog/ai-imaging-analysis-radiology-mdr AI radiology software is one of the most common SaMD categories. Here is how MDR classifies it and what evidence the Notified Body expects. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-pathology-mdr https://zechmeister-solutions.com/en/blog/ai-pathology-mdr Digital pathology AI sits in a regulatory grey zone between MDR and IVDR. Classification, scanner validation, and evidence requirements for pathology startups. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/predictive-analytics-medical-device https://zechmeister-solutions.com/en/blog/predictive-analytics-medical-device When does a predictive analytics model become a regulated medical device under MDR? The intended-purpose threshold and Rule 11 cascade explained. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/nlp-medical-devices-mdr https://zechmeister-solutions.com/en/blog/nlp-medical-devices-mdr When does NLP become a medical device under MDR? Clinical scribes, decision support, diagnostic NLP, and Rule 11 classification explained. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-remote-patient-monitoring-mdr https://zechmeister-solutions.com/en/blog/ai-remote-patient-monitoring-mdr AI remote patient monitoring under MDR: Rule 10 vs Rule 11 classification, alarm reliability, data drift, and lifecycle evidence explained. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/federated-learning-medical-devices https://zechmeister-solutions.com/en/blog/federated-learning-medical-devices How federated learning changes AI medical device development under MDR Annex VIII Rule 11, with GDPR data minimisation and EN 62304 evidence expectations. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/synthetic-data-ai-medical-device https://zechmeister-solutions.com/en/blog/synthetic-data-ai-medical-device When synthetic data is acceptable for AI medical device development under MDR Article 61 and Annex XIV, and when it is not a substitute for clinical evidence. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-medical-device-startup-playbook-2026 https://zechmeister-solutions.com/en/blog/ai-medical-device-startup-playbook-2026 The complete regulatory playbook for AI medical device startups in 2026: MDR plus the AI Act overlay, classification, evidence, lifecycle, and PMS. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/flinn-ai-tools-transforming-regulatory https://zechmeister-solutions.com/en/blog/flinn-ai-tools-transforming-regulatory AI is reshaping the grunt work of MedTech regulatory operations. Here is what tools like Flinn.ai actually do — and the complacency risk to watch for. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-automate-regulatory-documentation https://zechmeister-solutions.com/en/blog/ai-automate-regulatory-documentation AI can automate parts of regulatory documentation work. Here is what it does well, what it does poorly, and where the human stays in the loop. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-clinical-evaluation-literature-reviews https://zechmeister-solutions.com/en/blog/ai-clinical-evaluation-literature-reviews How AI tools accelerate MDR clinical evaluation literature reviews under Article 61 and Annex XIV, and where human judgement stays mandatory. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-pms-complaint-analysis-signal-detection https://zechmeister-solutions.com/en/blog/ai-pms-complaint-analysis-signal-detection AI can categorise complaints and surface PMS signals at scale. Here is how to use it under MDR without breaking the human-in-the-loop. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-advantage-regulatory-affairs-startups https://zechmeister-solutions.com/en/blog/ai-advantage-regulatory-affairs-startups How lean MedTech startups use AI in regulatory affairs to match big MedTech throughput under MDR Article 10 without shortcutting compliance. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/7-mistakes-ai-medtech-startups-mdr https://zechmeister-solutions.com/en/blog/7-mistakes-ai-medtech-startups-mdr An auditor's view of seven recurring MDR compliance mistakes AI MedTech startups make, from Rule 11 classification to retraining as significant change. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ai-ml-medical-device-compliance-checklist-2027 https://zechmeister-solutions.com/en/blog/ai-ml-medical-device-compliance-checklist-2027 The complete compliance checklist for AI/ML medical device startups in 2027 — spanning MDR, the AI Act layer, data governance, and post-market monitoring. AI, ML & Algorithmic Devices office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-electrical-safety-requirements https://zechmeister-solutions.com/en/blog/mdr-electrical-safety-requirements MDR Annex I requires medical electrical equipment to be safe. EN 60601-1 is the harmonised standard that gives you presumption of conformity. Here is how it fits together. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-edition-3-2-updates https://zechmeister-solutions.com/en/blog/iec-60601-1-edition-3-2-updates EN 60601-1 has accumulated amendments through A1, A12, A2, A13 — sometimes called Edition 3.2. Here are the changes that matter for startups. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/why-mdr-references-iec-60601-1 https://zechmeister-solutions.com/en/blog/why-mdr-references-iec-60601-1 MDR Article 8 lets harmonised standards demonstrate presumption of conformity. Here is how that mechanism works for electrical safety via EN 60601-1. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/basic-safety-essential-performance-iec-60601-1 https://zechmeister-solutions.com/en/blog/basic-safety-essential-performance-iec-60601-1 Basic safety and essential performance are the two core concepts of IEC 60601-1. Here is what they mean and how they map to MDR Annex I. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/electrical-safety-testing-medical-devices https://zechmeister-solutions.com/en/blog/electrical-safety-testing-medical-devices Electrical safety testing under IEC 60601-1 is done at a certified test lab. Here is what a startup should know before booking the lab. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-test-lab-process https://zechmeister-solutions.com/en/blog/iec-60601-1-test-lab-process The IEC 60601-1 test lab process is structured but unfamiliar to most startup founders. Here is what to expect from booking to certificate. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/electrical-hazard-protection-iec-60601-1 https://zechmeister-solutions.com/en/blog/electrical-hazard-protection-iec-60601-1 IEC 60601-1 defines Means of Protection (MOP) against electrical hazards. Here is what MOPP and MOOP mean and how to design for both. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mechanical-safety-iec-60601-1-mdr https://zechmeister-solutions.com/en/blog/mechanical-safety-iec-60601-1-mdr IEC 60601-1 includes mechanical safety requirements — stability, enclosures, moving parts. Here is how they map to MDR Annex I and what testing looks like. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/thermal-safety-iec-60601-1 https://zechmeister-solutions.com/en/blog/thermal-safety-iec-60601-1 MDR thermal safety using EN 60601-1 temperature limits: applied parts, hot surfaces, heat-balance, and what a test lab actually measures for burns protection. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-pems-iec-60601-1 https://zechmeister-solutions.com/en/blog/mdr-pems-iec-60601-1 PEMS sit at the intersection of EN 60601-1 and EN 62304. Here is how the two standards combine for programmable electrical medical systems under MDR. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/emc-requirements-iec-60601-1-2 https://zechmeister-solutions.com/en/blog/emc-requirements-iec-60601-1-2 MDR Annex I requires medical electrical devices to be electromagnetically compatible. EN 60601-1-2:2015+A1:2021 is the harmonised standard. Here is what it means in practice. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/emc-testing-medical-devices https://zechmeister-solutions.com/en/blog/emc-testing-medical-devices EN 60601-1-2 defines EMC testing for medical devices: emissions limits and immunity levels. Here is the practical scope of EMC testing for startups. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/design-for-emc-compliance https://zechmeister-solutions.com/en/blog/design-for-emc-compliance Design choices that prevent EMC failures in medical devices: PCB layout, shielding, grounding, cables, and pre-test prep aligned to MDR Annex I §14.5. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-6-usability-cross-reference https://zechmeister-solutions.com/en/blog/iec-60601-1-6-usability-cross-reference How IEC 60601-1-6 cross-references EN 62366-1 for medical electrical equipment, and what a single usability file must contain under MDR. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-8-alarm-systems https://zechmeister-solutions.com/en/blog/iec-60601-1-8-alarm-systems How IEC 60601-1-8 defines alarm priorities, audio and visual signals, and distributed alarms for MDR-compliant medical electrical equipment. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-9-environmentally-conscious-design https://zechmeister-solutions.com/en/blog/iec-60601-1-9-environmentally-conscious-design IEC 60601-1-9 applies environmentally conscious design to medical devices. Lifecycle impact, design choices, and evidence for the MDR technical file. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-10-closed-loop-controller https://zechmeister-solutions.com/en/blog/iec-60601-1-10-closed-loop-controller IEC 60601-1-10 governs closed-loop controllers in medical devices. Lifecycle activities, validation, failure-mode analysis for MDR compliance. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-11-home-healthcare https://zechmeister-solutions.com/en/blog/iec-60601-1-11-home-healthcare How IEC 60601-1-11 extends EN 60601-1 for home use devices under MDR — lay users, mains variability, IFU obligations, PMS implications. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-1-12-emergency-environment https://zechmeister-solutions.com/en/blog/iec-60601-1-12-emergency-environment How IEC 60601-1-12 extends EN 60601-1 for EMS, ambulance, field and air-ambulance devices under MDR — ruggedization, EMC, battery autonomy. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iec-60601-2-particular-standards https://zechmeister-solutions.com/en/blog/iec-60601-2-particular-standards How the IEC 60601-2-xx particular standards work under MDR, how to find the right one for your device, and how conflicts with EN 60601-1 are resolved. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/functional-safety-iec-62443-iec-61508 https://zechmeister-solutions.com/en/blog/functional-safety-iec-62443-iec-61508 When functional safety concepts from IEC 61508 and IEC 62443 add value to MDR medical device development, and what you cannot claim about them. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/power-supply-safety-iec-60601-1 https://zechmeister-solutions.com/en/blog/power-supply-safety-iec-60601-1 How EN 60601-1 shapes medical power supply design: isolation classes, leakage limits, and qualifying COTS medical-grade supplies for the technical file. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/battery-safety-portable-medical-equipment https://zechmeister-solutions.com/en/blog/battery-safety-portable-medical-equipment Battery selection, charging, thermal runaway, BMS design, and transport for portable medical devices under MDR and EN 60601-1. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/wireless-device-compliance-red https://zechmeister-solutions.com/en/blog/wireless-device-compliance-red Wireless medical devices must meet both MDR and Radio Equipment Directive 2014/53/EU. Here is how to plan the dual-compliance path without surprises. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medical-device-packaging-design-mdr https://zechmeister-solutions.com/en/blog/medical-device-packaging-design-mdr Packaging is a regulated component of the medical device. Here is what MDR Annex I and the EN ISO 11607 series actually require, and how to pass audit. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/environmental-testing-medical-devices https://zechmeister-solutions.com/en/blog/environmental-testing-medical-devices MDR Annex I §17.1 requires devices to work under foreseeable environmental conditions. Here is how to plan climate, vibration, and drop testing early. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/systems-engineering-v-model-startups https://zechmeister-solutions.com/en/blog/systems-engineering-v-model-startups How startups can apply a lean systems engineering V-model to medical device development under MDR and EN ISO 13485 without drowning in paperwork. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/system-requirements-medical-devices https://zechmeister-solutions.com/en/blog/system-requirements-medical-devices How to write, manage and trace system requirements for medical devices under MDR and EN ISO 13485 clause 7.3.3, from GSPR to verifiable specifications. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/system-architecture-medical-devices-mdr https://zechmeister-solutions.com/en/blog/system-architecture-medical-devices-mdr What a system architecture document must contain for a medical device under MDR Annex II, including hardware/software boundaries and safety segregation. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/system-integration-verification-testing https://zechmeister-solutions.com/en/blog/system-integration-verification-testing System integration and verification testing for medical devices under MDR: plan, traceability, evidence, and handling failures the auditor will accept. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hardware-development-pcb-design https://zechmeister-solutions.com/en/blog/hardware-development-pcb-design Hardware development and PCB design for medical devices under MDR: safety and EMC decisions, schematic and BOM control, and evidence auditors request. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/firmware-development-iec-62304-hardware https://zechmeister-solutions.com/en/blog/firmware-development-iec-62304-hardware Firmware for medical devices under EN 62304 and EN 60601-1: hardware abstraction, real-time constraints, and joint hardware and firmware verification. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/electrical-safety-costs-iec-60601-1 https://zechmeister-solutions.com/en/blog/electrical-safety-costs-iec-60601-1 Realistic cost ranges for EN 60601-1 and EN 60601-1-2 testing under MDR. Categories, drivers, and where startups can save without cutting corners. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-iec-60601-1-test-failures https://zechmeister-solutions.com/en/blog/common-iec-60601-1-test-failures The eight most common IEC 60601-1 test failures in MedTech startup labs — each with the test that caught it and the design fix. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/electrical-safety-checklist-startups https://zechmeister-solutions.com/en/blog/electrical-safety-checklist-startups A startup-sized electrical safety checklist against EN 60601-1 and EN 60601-1-2, prioritized by risk of failure and mapped to MDR Annex I. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-regulation-medical-devices-primer-eu-startups https://zechmeister-solutions.com/en/blog/fda-regulation-medical-devices-primer-eu-startups The FDA uses a different framework than the MDR. Here is the primer for EU founders who want to understand what US market access actually requires. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-vs-mdr-fundamental-differences https://zechmeister-solutions.com/en/blog/fda-vs-mdr-fundamental-differences The structural differences between FDA and EU MDR — regulation vs guidance, notified body vs agency, classification logic, evidence and post-market philosophy. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-device-classification-eu-startups https://zechmeister-solutions.com/en/blog/fda-device-classification-eu-startups FDA classifies devices as Class I, II, or III by risk and pathway. Here is how the FDA classification compares to MDR for EU founders considering US entry. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/510k-process-fda-clearance https://zechmeister-solutions.com/en/blog/510k-process-fda-clearance The FDA 510(k) pathway is how most medical devices reach the US market. Here is the process explained at a level useful for EU startups considering US entry. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/substantial-equivalence-510k-predicate-strategy https://zechmeister-solutions.com/en/blog/substantial-equivalence-510k-predicate-strategy FDA 510(k) clearance depends on substantial equivalence to a predicate device. Here is how EU startups should think about predicate selection. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-de-novo-classification https://zechmeister-solutions.com/en/blog/fda-de-novo-classification The FDA De Novo pathway is for novel devices that have no predicate but moderate risk. Here is the pathway at general framing for EU startups. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-pma-premarket-approval https://zechmeister-solutions.com/en/blog/fda-pma-premarket-approval FDA PMA premarket approval explained for EU founders: what triggers it, evidence demands, timelines, fees, and how it compares to MDR Class III. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-510k-vs-mdr-ce-marking https://zechmeister-solutions.com/en/blog/fda-510k-vs-mdr-ce-marking A side-by-side comparison of FDA 510(k) clearance and MDR CE marking: classification, evidence, QMS, timeline, and cost for EU startups targeting both. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/dual-submission-strategy-ce-fda https://zechmeister-solutions.com/en/blog/dual-submission-strategy-ce-fda Pursuing CE marking and FDA clearance simultaneously can save time but doubles the work. Here is the dual submission strategy for EU MedTech startups. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-establishment-registration-eu-manufacturers https://zechmeister-solutions.com/en/blog/fda-establishment-registration-eu-manufacturers FDA establishment registration EU manufacturers guide: who must register, fees, US Agent rules, device listing, UDI, and common errors to avoid. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-labeling-vs-mdr https://zechmeister-solutions.com/en/blog/fda-labeling-vs-mdr FDA labeling vs MDR compared side by side: what overlaps, what diverges, and whether a single label can serve both US and EU markets. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-qsr-qmsr-transition-2026 https://zechmeister-solutions.com/en/blog/fda-qsr-qmsr-transition-2026 The FDA has been harmonising its Quality System Regulation with ISO 13485 as the QMSR. Here is what EU startups need to know about the transition in 2026. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-qmsr-iso-13485-alignment https://zechmeister-solutions.com/en/blog/fda-qmsr-iso-13485-alignment FDA QMSR ISO 13485 alignment explained: what changed, what stays FDA-specific, and how one QMS can serve both US and EU MDR markets. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-clinical-data-ide-studies https://zechmeister-solutions.com/en/blog/fda-clinical-data-ide-studies FDA Investigational Device Exemption studies are how you generate clinical evidence for US submissions. Here is when an IDE is required and what it involves at a general level. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-software-guidance-eu-comparison https://zechmeister-solutions.com/en/blog/fda-software-guidance-eu-comparison FDA software regulation differs from MDR in pathway, documentation, and lifecycle. Here is the comparison for EU SaMD startups at general framing. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-ai-ml-pccp https://zechmeister-solutions.com/en/blog/fda-ai-ml-pccp The FDA's Predetermined Change Control Plan lets AI devices evolve within pre-approved boundaries. Here is how it compares to the MDR approach at general framing. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-cybersecurity-section-524b https://zechmeister-solutions.com/en/blog/fda-cybersecurity-section-524b FDA cybersecurity Section 524B explained: SBOM, vulnerability handling, lifecycle plans, and how it compares to MDR cybersecurity expectations. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-udi-gudid-eu-manufacturers https://zechmeister-solutions.com/en/blog/fda-udi-gudid-eu-manufacturers FDA UDI and GUDID for EU manufacturers: how GUDID differs from EUDAMED, dual submission, issuing entities, and the one-label strategy. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-postmarket-mdr-recalls-corrections https://zechmeister-solutions.com/en/blog/fda-postmarket-mdr-recalls-corrections FDA postmarket obligations for EU manufacturers: Medical Device Reporting under 21 CFR 803, recalls and corrections under 21 CFR 806, compared to EU vigilance. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/us-agent-fda-eu-startups https://zechmeister-solutions.com/en/blog/us-agent-fda-eu-startups Foreign manufacturers selling devices in the US must designate a US Agent to interact with FDA. Here is what the role does and how to choose one. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-breakthrough-device-designation https://zechmeister-solutions.com/en/blog/fda-breakthrough-device-designation FDA Breakthrough Device Designation explained for EU startups: eligibility, application, sprint discussions, priority review, and what it does not do. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fda-eua-emergency-use https://zechmeister-solutions.com/en/blog/fda-eua-emergency-use What FDA Emergency Use Authorization is, when it applies, and how EU MedTech startups should think about it — including why MDR has no direct equivalent. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/us-regulatory-consultant-eu-startup https://zechmeister-solutions.com/en/blog/us-regulatory-consultant-eu-startup Practical guide for EU MedTech founders evaluating US regulatory consultants for 510(k), De Novo, PMA and QMSR work. Red flags, contracts, fees. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/uk-mhra-ukca-marking-2026 https://zechmeister-solutions.com/en/blog/uk-mhra-ukca-marking-2026 The UK regulates medical devices through the MHRA with UKCA marking (and continued CE recognition in transition). Here is where things stand in 2026 for EU startups. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/swiss-medical-device-meddo https://zechmeister-solutions.com/en/blog/swiss-medical-device-meddo Switzerland's MedDO mirrors MDR, but since the 2021 MRA expiry Switzerland is a third country. CH-REP, Swissmedic registration, dual-market reality. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/japan-pmda-medical-device-eu-startups https://zechmeister-solutions.com/en/blog/japan-pmda-medical-device-eu-startups Japan's PMDA and PMD Act framework for EU MedTech founders: classification I-IV, MAH requirement, evidence expectations, sequencing vs CE mark. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/china-nmpa-medical-devices https://zechmeister-solutions.com/en/blog/china-nmpa-medical-devices China's NMPA is a major but distinct medical device regulator. Here is what EU startups should know about market access at general framing. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/australia-tga-medical-device https://zechmeister-solutions.com/en/blog/australia-tga-medical-device How EU MedTech startups enter Australia via the TGA: ARTG inclusion, sponsor model, classification, MDSAP route, and common surprises. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/canada-health-canada-mdl-mdsap https://zechmeister-solutions.com/en/blog/canada-health-canada-mdl-mdsap Health Canada MDL classes, mandatory MDSAP for Class II-IV, application contents, timelines, and why Canada gets cheaper if you're already MDSAP certified. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/brazil-anvisa-medical-device https://zechmeister-solutions.com/en/blog/brazil-anvisa-medical-device How EU MedTech startups enter Brazil via ANVISA: classification, BRH sponsor, BPF inspection, MDSAP route, registration timelines, and Portuguese labelling. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/south-korea-mfds-medical-device https://zechmeister-solutions.com/en/blog/south-korea-mfds-medical-device South Korea MFDS medical device approval for EU startups: classification, KGMP audits, local representative, Korean clinical data expectations and timelines. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/india-cdsco-medical-device https://zechmeister-solutions.com/en/blog/india-cdsco-medical-device India CDSCO medical device regulation for EU startups: A-D classification, Authorized Indian Agent, registration certificates, and realistic timelines. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/saudi-arabia-sfda-medical-device https://zechmeister-solutions.com/en/blog/saudi-arabia-sfda-medical-device Saudi Arabia SFDA medical device regulation for EU startups: classification, Authorized Representative, MDNR registration, GCC cooperation, timelines. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/imdrf-global-harmonization-startups https://zechmeister-solutions.com/en/blog/imdrf-global-harmonization-startups The International Medical Device Regulators Forum creates harmonised guidance across jurisdictions. Here is what IMDRF is and how startups can use it strategically. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdsap-single-audit-multiple-markets https://zechmeister-solutions.com/en/blog/mdsap-single-audit-multiple-markets MDSAP lets you satisfy five regulatory authorities with one audit. Here is what it is, what it covers, and when a MedTech startup should pursue it. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/international-expansion-sequencing https://zechmeister-solutions.com/en/blog/international-expansion-sequencing After CE marking, which country should you enter next? Here is a sequencing framework based on regulatory cost, market size, and strategic fit. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-strategy-global-market-access https://zechmeister-solutions.com/en/blog/regulatory-strategy-global-market-access A global regulatory strategy is not a stack of country plans. It is a scalable framework where each market reuses the same evidence and QMS. Here is how to build one. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/country-specific-registration-hidden-costs https://zechmeister-solutions.com/en/blog/country-specific-registration-hidden-costs Country-specific medical device registration costs nobody mentions in pitch decks: local reps, translations, fees, and how they compound across markets. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/import-export-medical-devices-customs https://zechmeister-solutions.com/en/blog/import-export-medical-devices-customs Medical devices import export customs free sale certificate guide: purpose, issuers, validity, customs codes, and common shipment failures. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/local-representatives-by-market https://zechmeister-solutions.com/en/blog/local-representatives-by-market Local representative medical device international guide: EU AR, US Agent, CH-REP, UKRP roles, contract essentials, single vs multi-market firms. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/translation-requirements-international-registration https://zechmeister-solutions.com/en/blog/translation-requirements-international-registration Translation requirements medical device international: what must be translated, by whom, at what cost, and the errors that blow up registrations. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prioritize-international-markets-medtech https://zechmeister-solutions.com/en/blog/prioritize-international-markets-medtech Resource-limited startups cannot enter every market at once. Here is the prioritisation framework for MedTech international expansion. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/true-cost-international-market-access-budget https://zechmeister-solutions.com/en/blog/true-cost-international-market-access-budget True cost international market access medical device: a per-country budget framework applied to five markets, with registration, AR, translation and maintenance. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/common-mistakes-eu-startups-us-market https://zechmeister-solutions.com/en/blog/common-mistakes-eu-startups-us-market EU MedTech startups make predictable mistakes when crossing the Atlantic. Here are the seven most common ones and how to avoid them. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/international-market-access-checklist-2027 https://zechmeister-solutions.com/en/blog/international-market-access-checklist-2027 The international market access checklist for MedTech startups in 2027: EU, US, UK, Canada, Australia, Japan — the regulatory checkpoints and cost reality for each. FDA & International Market Access office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/product-market-fit-medtech-startups https://zechmeister-solutions.com/en/blog/product-market-fit-medtech-startups Product-market fit for MedTech is not SaaS PMF. You cannot test the technology with customers, but you can verify the market. Here is how to find PMF before MDR eats runway. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-paradox https://zechmeister-solutions.com/en/blog/medtech-startup-paradox In MedTech, you need PMF before regulation, but you also need regulation before you can ship. The paradox breaks most first-time founders. Here is how to resolve it. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/validate-medtech-idea-before-mdr https://zechmeister-solutions.com/en/blog/validate-medtech-idea-before-mdr Before you spend a euro on MDR, verify the market for your MedTech idea. Here is the pre-regulatory validation sequence Felix uses with every MedTech founder. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/beachhead-market-strategy-medtech https://zechmeister-solutions.com/en/blog/beachhead-market-strategy-medtech Pick one narrow market. Get CE marking for that specific intended purpose. Expand later. Here is the beachhead strategy adapted for regulated MedTech startups. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/wellness-first-medical-device-later https://zechmeister-solutions.com/en/blog/wellness-first-medical-device-later Some MedTech products can launch as wellness first and later transition to medical device status. Here is when the strategy works, when it does not, and the legal boundary. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/define-intended-purpose-without-over-constraining https://zechmeister-solutions.com/en/blog/define-intended-purpose-without-over-constraining Your intended purpose must be specific enough for classification but not so narrow it boxes you in. Here is how to write one that satisfies both. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-customer-discovery https://zechmeister-solutions.com/en/blog/medtech-customer-discovery Customer discovery in MedTech is not 'talk to users.' It is interviewing clinicians, patients, and hospital buyers with different questions for each. Here is how to do it right. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/decision-making-units-medtech-sales https://zechmeister-solutions.com/en/blog/decision-making-units-medtech-sales The champion who loves your device is not the person who signs the purchase order. Here is how to map the full decision-making unit for MedTech B2B sales. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-value-chain https://zechmeister-solutions.com/en/blog/medtech-value-chain The MedTech value chain runs from manufacturer through importer, distributor, hospital procurement, clinician, payer, and patient. Here is how MDR maps to each. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hospital-procurement-medtech-strategy https://zechmeister-solutions.com/en/blog/hospital-procurement-medtech-strategy How hospital procurement actually works under MEAT criteria and value analysis committees, and why CE mark is necessary but not sufficient to win deals. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/selling-hospitals-vs-direct-to-patient https://zechmeister-solutions.com/en/blog/selling-hospitals-vs-direct-to-patient How B2B hospital sales and direct-to-patient MedTech differ under MDR on lay-user IFU duties, distance selling rules, reimbursement, and evidence. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-business-model-analysis https://zechmeister-solutions.com/en/blog/medtech-business-model-analysis MedTech revenue models are constrained by reimbursement, procurement cycles, and device class. Here is how to choose the right one. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/razor-blade-medtech-single-use https://zechmeister-solutions.com/en/blog/razor-blade-medtech-single-use The razor-and-blade revenue model works well for MedTech when single-use consumables carry the margin. Here is how to structure it under MDR. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/saas-pricing-medical-software-mdr https://zechmeister-solutions.com/en/blog/saas-pricing-medical-software-mdr How subscription pricing, feature flags, and tiered plans interact with MDR Annex VIII Rule 11, significant change rules, and MDCG 2019-11 Rev.1. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-competitive-analysis https://zechmeister-solutions.com/en/blog/medtech-competitive-analysis Competitive analysis for MedTech is not a grid of feature checkmarks. It is understanding how the DMU actually compares options and where your device creates real asymmetry. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/two-phase-development-startup-strategy https://zechmeister-solutions.com/en/blog/two-phase-development-startup-strategy Two-phase development is a startup strategy, not just a regulatory tactic. Phase 1 proves the product is worth building. Phase 2 makes it certifiable. Here is the strategic case. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mvp-medical-devices-mdr https://zechmeister-solutions.com/en/blog/mvp-medical-devices-mdr What a minimum viable product actually means for MDR medical devices, what can ship without CE, and how to avoid locking intended purpose too early. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pre-marketing-compliance-strategy https://zechmeister-solutions.com/en/blog/pre-marketing-compliance-strategy How to sequence clinical data, technical documentation, QMS and CER work during the pre-launch phase so a notified body review does not sink your timeline. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-business-plan-investors-regulators https://zechmeister-solutions.com/en/blog/medtech-business-plan-investors-regulators How to write a MedTech business plan that works for both investors and regulators — dual-audience structure, intended purpose, classification, and CER strategy. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-go-to-market-strategy https://zechmeister-solutions.com/en/blog/medtech-go-to-market-strategy The CE mark is the start of GTM, not the end. Here is the MedTech GTM playbook from certification to first paying hospital. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pricing-strategy-medical-devices-europe https://zechmeister-solutions.com/en/blog/pricing-strategy-medical-devices-europe Pricing strategy medical devices Europe: cost structure, margin floors, payer constraints, country negotiation, and why low pricing kills MedTech. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hta-market-access-pricing https://zechmeister-solutions.com/en/blog/hta-market-access-pricing HTA market access pricing medical device: how Joint Clinical Assessments, national HTA bodies and MDR evidence overlap shape your launch plan. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/kol-strategy-medtech-startups https://zechmeister-solutions.com/en/blog/kol-strategy-medtech-startups KOL strategy MedTech startups: identify clinical champions, structure advisory relationships, and respect MDR Article 7 promotional rules. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/evidence-generation-strategy-medtech https://zechmeister-solutions.com/en/blog/evidence-generation-strategy-medtech Evidence generation strategy MedTech: one integrated stack that satisfies MDR Article 61, PMS, HTA bodies, and payers without running two trials. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/when-to-pivot-medtech-regulatory https://zechmeister-solutions.com/en/blog/when-to-pivot-medtech-regulatory Pivoting in MedTech is more expensive than in SaaS because the regulatory work is partly device-specific. Here is when to pivot and how to keep regulatory value. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-failure-modes-10-reasons https://zechmeister-solutions.com/en/blog/medtech-startup-failure-modes-10-reasons The ten most common reasons MedTech startups die — each with the specific failure pattern Tibor and Felix have watched repeat across dozens of companies. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/case-study-samd-ce-marked-12-months https://zechmeister-solutions.com/en/blog/case-study-samd-ce-marked-12-months A 12-month CE marking timeline for a SaMD startup is achievable with the right discipline. Here is the anonymised case study and the choices that made it work. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/case-study-hardware-medtech-out-of-money https://zechmeister-solutions.com/en/blog/case-study-hardware-medtech-out-of-money Anonymized case study of a hardware MedTech startup that ran out of money during MDR conformity assessment, and what they should have done. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/case-study-pivoting-wellness-medical-device https://zechmeister-solutions.com/en/blog/case-study-pivoting-wellness-medical-device Anonymized case study of pivoting from wellness to medical device: how a beachhead strategy and a disciplined intended purpose rewrite enabled CE marking. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/case-study-ai-diagnostics-failed-nb-audit https://zechmeister-solutions.com/en/blog/case-study-ai-diagnostics-failed-nb-audit AI diagnostics startup failed Notified Body audit: a composite teaching case on intended purpose drift, weak clinical evidence, and model documentation gaps. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/case-study-university-research-ce-mark-24-months https://zechmeister-solutions.com/en/blog/case-study-university-research-ce-mark-24-months Spinning a university research project into a CE-marked medical device in 24 months is possible but unusual. Here is the anonymised case study. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/no-bullshit-medtech-startup-timelines https://zechmeister-solutions.com/en/blog/no-bullshit-medtech-startup-timelines Real MedTech timelines are 2-5x what founders plan for. Here is the honest version — phase by phase — of what actually takes how long from idea to revenue. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/how-long-until-revenue-medtech-timeline https://zechmeister-solutions.com/en/blog/how-long-until-revenue-medtech-timeline How long until a MedTech startup sees its first euro? Realistic revenue timelines by class, hidden delays, and what actually shortens the path. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-milestones-idea-to-market https://zechmeister-solutions.com/en/blog/medtech-startup-milestones-idea-to-market The 14 milestones every MedTech startup hits from idea to market, what each unlocks for funding and hiring, and how long they realistically take. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-strategy-supports-business-strategy https://zechmeister-solutions.com/en/blog/regulatory-strategy-supports-business-strategy Regulatory strategy is not separate from business strategy — it is a dimension of it. Here is how to align them so MDR work accelerates rather than drains the business. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/diy-vs-experts-decision-framework https://zechmeister-solutions.com/en/blog/diy-vs-experts-decision-framework The DIY vs expert regulatory decision is not a single choice — it's a series of scoped decisions. Here is the framework for each. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/when-to-bring-in-regulatory-consultant https://zechmeister-solutions.com/en/blog/when-to-bring-in-regulatory-consultant Knowing when to hire an MDR consultant is as important as knowing how to evaluate one. Here are the concrete signs that mean it is time. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/subtract-to-ship-applied-medtech https://zechmeister-solutions.com/en/blog/subtract-to-ship-applied-medtech Subtract to Ship is the discipline of removing work that does not earn its place. Here is how to apply it specifically to MedTech startup operations. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/learn-from-medtech-incumbents-without-copying https://zechmeister-solutions.com/en/blog/learn-from-medtech-incumbents-without-copying How MedTech startups can borrow the regulatory rigor of big incumbents without inheriting their bloated committees, ceremony, and paperwork-for-paperwork. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/platform-vs-point-solution-medtech https://zechmeister-solutions.com/en/blog/platform-vs-point-solution-medtech Platform vs point solution for MedTech startups: how intended purpose, classification, and technical file structure shape the right strategic choice. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/open-innovation-medtech-hospitals-research https://zechmeister-solutions.com/en/blog/open-innovation-medtech-hospitals-research Open innovation MedTech hospitals research: structuring collaborations under MDR Articles 62-82, who owns data and IP, and where manufacturer duty stays. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/ip-strategy-medtech-startups https://zechmeister-solutions.com/en/blog/ip-strategy-medtech-startups IP strategy for MedTech startups: patents, trade secrets, freedom to operate, and how technical file confidentiality interacts with EUDAMED transparency. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-metrics-beyond-revenue https://zechmeister-solutions.com/en/blog/medtech-startup-metrics-beyond-revenue MedTech startup metrics beyond revenue: the regulatory KPIs, PMS signals and NB interaction data that actually predict whether you will ship and scale. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-ecosystem-europe-2026 https://zechmeister-solutions.com/en/blog/medtech-ecosystem-europe-2026 MedTech startup ecosystem Europe 2026: where the clusters are, how to read accelerators and public funding, and what to look for before joining a hub. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/complete-medtech-startup-playbook-2027 https://zechmeister-solutions.com/en/blog/complete-medtech-startup-playbook-2027 The complete MedTech startup playbook for 2027: the end-to-end path from idea to CE marking, with every decision point, cost bracket, and time window. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/funding-medtech-startup https://zechmeister-solutions.com/en/blog/funding-medtech-startup Funding a MedTech startup is not the same as funding SaaS. The cost of regulation, the time to revenue, and the investor expectations all differ. Here is the complete guide. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-more-capital-than-saas https://zechmeister-solutions.com/en/blog/medtech-more-capital-than-saas MedTech startups need 3-10x more capital than SaaS to reach revenue. The difference is not technical complexity — it is the 18-24 month regulatory path. Here is the math. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pre-seed-seed-funding-medtech https://zechmeister-solutions.com/en/blog/pre-seed-seed-funding-medtech Raising pre-seed and seed for a MedTech startup is harder than SaaS because investors want evidence of the regulatory path. Here is what they actually want to see. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/series-a-medtech-startups https://zechmeister-solutions.com/en/blog/series-a-medtech-startups Series A in MedTech needs more than PMF. Investors want a regulatory milestone, clinical evidence plan, and path to revenue. Here is what to show. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/venture-capital-medtech-europe-2026 https://zechmeister-solutions.com/en/blog/venture-capital-medtech-europe-2026 European MedTech VC has matured but still lags US deal sizes. Here is the 2026 investor landscape and what MedTech founders should expect at each round. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/angel-investors-medtech https://zechmeister-solutions.com/en/blog/angel-investors-medtech Where MedTech angel investors concentrate, what they fund, and why regulatory readiness is the filter that decides who writes the first check. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/non-dilutive-funding-medtech https://zechmeister-solutions.com/en/blog/non-dilutive-funding-medtech Non-dilutive funding can carry a MedTech startup through the regulatory valley without giving up equity. Here is the landscape across Europe in 2026. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eu-funding-medtech-startups https://zechmeister-solutions.com/en/blog/eu-funding-medtech-startups Horizon Europe, EIC Accelerator, EIT Health — the EU funding stack for MedTech is complex. Here is the overview at general framing. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/austrian-funding-medtech-startups https://zechmeister-solutions.com/en/blog/austrian-funding-medtech-startups Austria has one of Europe's strongest MedTech funding ecosystems. Here is how AWS, FFG, and regional programs work for startups — with the honest caveats on current terms. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/german-funding-medtech-startups https://zechmeister-solutions.com/en/blog/german-funding-medtech-startups EXIST, BMBF, and state-level funding for German MedTech startups — eligibility, regulatory milestones tied to disbursement, and what to apply for when. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/swiss-funding-medtech-startups https://zechmeister-solutions.com/en/blog/swiss-funding-medtech-startups Innosuisse, cantonal programmes, and the third-country reality of Switzerland under MDR — how Swiss MedTech startups fund the extra regulatory burden. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/eic-accelerator-medtech-application https://zechmeister-solutions.com/en/blog/eic-accelerator-medtech-application The EIC Accelerator is the largest non-dilutive grant programme for European MedTech. Here is how to write a winning application at general framing. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pitch-medtech-regulatory-slide https://zechmeister-solutions.com/en/blog/pitch-medtech-regulatory-slide Every MedTech pitch deck needs a regulatory slide. Here is what MedTech investors actually want to see on it — and what kills the round. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/investor-due-diligence-regulatory-qms https://zechmeister-solutions.com/en/blog/investor-due-diligence-regulatory-qms What MedTech investors check in regulatory and QMS due diligence: red flags that kill rounds, the evidence pack to assemble, who gets interrogated. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/strategic-investors-corporate-vc-medtech https://zechmeister-solutions.com/en/blog/strategic-investors-corporate-vc-medtech When strategic investors and corporate VCs make sense for MedTech startups, what they bring beyond money, and the alignment risks to weigh first. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/revenue-before-ce-mark-legal-options https://zechmeister-solutions.com/en/blog/revenue-before-ce-mark-legal-options Legal ways to generate revenue before CE mark: services, custom-made devices, R&D contracts, and investigational use — with MDR citations. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/crowdfunding-medical-devices https://zechmeister-solutions.com/en/blog/crowdfunding-medical-devices Crowdfunding medical devices legally: MDR Article 7 promotional traps, Article 5 placement rules, pre-orders, and equity crowdfunding alternatives. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-budget-planning https://zechmeister-solutions.com/en/blog/medtech-startup-budget-planning A MedTech startup budget must allocate for regulatory work from day one. Here is the line-by-line budget template and the common traps founders fall into. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/true-cost-ce-marking-transparent-breakdown https://zechmeister-solutions.com/en/blog/true-cost-ce-marking-transparent-breakdown The real cost of CE marking a medical device in 2026, broken down by category and class. Useful for investor pitches and founder sanity. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/burn-rate-management-medtech https://zechmeister-solutions.com/en/blog/burn-rate-management-medtech MedTech burn rate is determined by regulatory milestones, not feature releases. Here is how to manage burn rate so you reach CE marking without a gap round. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/financial-modeling-medtech-startups https://zechmeister-solutions.com/en/blog/financial-modeling-medtech-startups How to build a defensible financial model for a MedTech startup when MDR timelines, notified body queues, and audit cycles drive every assumption. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/reimbursement-strategy-europe-startup-guide https://zechmeister-solutions.com/en/blog/reimbursement-strategy-europe-startup-guide A startup guide to reimbursement strategy for medical devices in Europe: why CE mark is not enough, how HTA works, and how to sequence markets. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/health-insurance-reimbursement-europe https://zechmeister-solutions.com/en/blog/health-insurance-reimbursement-europe Health insurance reimbursement in Europe is country-specific, slow, and the gating factor for revenue. Here is the founder's primer. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/german-reimbursement-medical-devices https://zechmeister-solutions.com/en/blog/german-reimbursement-medical-devices Germany is Europe's largest medical device market. Here is the GKV, NUB, and DRG reimbursement framework for MedTech startups at general framing. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/french-reimbursement-lppr-cnedimts https://zechmeister-solutions.com/en/blog/french-reimbursement-lppr-cnedimts How French reimbursement works for medical devices: LPPR listing, CNEDIMTS evaluation, evidence demands, timelines, and common rejection reasons. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/uk-reimbursement-nhs-nice https://zechmeister-solutions.com/en/blog/uk-reimbursement-nhs-nice UK reimbursement medical devices NHS NICE: how NHS procurement, NICE appraisal and UKCA marking fit together, and how EU startups should sequence entry. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/austrian-reimbursement-medical-devices https://zechmeister-solutions.com/en/blog/austrian-reimbursement-medical-devices How Austrian social insurance, hospital budgets, and the LKF system reimburse medical devices — and what MedTech founders need to prepare. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/health-economic-evaluation-medical-devices https://zechmeister-solutions.com/en/blog/health-economic-evaluation-medical-devices What health economic evaluation actually is for MedTech startups — cost-effectiveness, budget impact, QALYs, and when to commission a study. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hta-submissions-medical-devices https://zechmeister-solutions.com/en/blog/hta-submissions-medical-devices Health Technology Assessment bodies decide whether a device deserves public coverage. Here is how to prepare the evidence submission at general framing. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/coverage-with-evidence-development-ced https://zechmeister-solutions.com/en/blog/coverage-with-evidence-development-ced How coverage with evidence development (CED) lets MedTech startups get reimbursed while generating the clinical data payers demand. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/value-based-pricing-medical-devices https://zechmeister-solutions.com/en/blog/value-based-pricing-medical-devices Value-based pricing medical devices: how outcome-based contracting works, evidence you need, risks, and how MDR PMS becomes your data backbone. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/reimbursement-digital-health-europe-beyond-diga https://zechmeister-solutions.com/en/blog/reimbursement-digital-health-europe-beyond-diga Reimbursement digital health Europe beyond DiGA: Germany, France PECAN, Belgium m-Health. Country-by-country evidence, MDR overlap, dual-pathway strategy. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/reimbursement-strategy-affects-regulatory-strategy https://zechmeister-solutions.com/en/blog/reimbursement-strategy-affects-regulatory-strategy Reimbursement strategy regulatory strategy MedTech: plan both together. Evidence stack design, Article 61, classification and HTA, startup playbook. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-exit-strategy https://zechmeister-solutions.com/en/blog/medtech-exit-strategy MedTech exits look different from SaaS exits. Here is the M&A, IPO, and partnership reality for MedTech startups in Europe. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-ma-acquirers-evaluate-regulatory https://zechmeister-solutions.com/en/blog/medtech-ma-acquirers-evaluate-regulatory How MedTech acquirers diligence regulatory assets under MDR — CE certificate transferability, QMS maturity, CER currency, and PMS continuity. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/licensing-technology-medtech https://zechmeister-solutions.com/en/blog/licensing-technology-medtech How to license MedTech technology to established companies under MDR — who becomes the manufacturer, royalty structures, IP carve-outs, and regulatory hand-over. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-valuation-regulatory-milestones https://zechmeister-solutions.com/en/blog/medtech-startup-valuation-regulatory-milestones MedTech valuations are anchored to regulatory milestones more than to revenue. Here is how each milestone moves the value. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cash-flow-management-medtech https://zechmeister-solutions.com/en/blog/cash-flow-management-medtech Cash flow management for MedTech startups — timing regulatory costs against revenue, managing the cash trough, and surviving the MDR Article 52 assessment cycle. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/extend-runway-cost-saving-regulated-product https://zechmeister-solutions.com/en/blog/extend-runway-cost-saving-regulated-product Extend runway in MedTech without breaking MDR. What costs you can defer, what must stay, and how to stretch capital without losing compliance. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-funding-checklist-2027 https://zechmeister-solutions.com/en/blog/medtech-startup-funding-checklist-2027 The MedTech startup funding checklist for 2027. Regulatory deliverables mapped to each round from pre-seed to Series A, with investor red flags. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-team-key-roles https://zechmeister-solutions.com/en/blog/medtech-startup-team-key-roles The MedTech team that ships is not the team that has hired everyone. It is the team that has the right 3-5 roles filled honestly. Here is the core team every startup needs. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hiring-regulatory-affairs-startup https://zechmeister-solutions.com/en/blog/hiring-regulatory-affairs-startup Hiring your first regulatory affairs person is a high-leverage decision. Here is how to evaluate candidates, the red flags to avoid, and what the right hire looks like. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/qualification-gap-analysis-medtech-startups https://zechmeister-solutions.com/en/blog/qualification-gap-analysis-medtech-startups A qualification gap analysis identifies missing competencies before they become audit findings. Here is the startup-scale method. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prrc-startup-hiring-outsourcing-training https://zechmeister-solutions.com/en/blog/prrc-startup-hiring-outsourcing-training The PRRC role under MDR Article 15 is required but flexible for small startups. Here is the honest decision framework between hiring, outsourcing, and training internally. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/building-qa-ra-quality-team-startup https://zechmeister-solutions.com/en/blog/building-qa-ra-quality-team-startup A 3-person MedTech startup cannot afford a 5-person QA/RA team — but it also cannot afford the absence of one. Here is how to structure the minimum that works. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/fractional-cto-cmo-regulatory-head https://zechmeister-solutions.com/en/blog/fractional-cto-cmo-regulatory-head When fractional CTO, CMO, and regulatory head roles make sense for MedTech startups under MDR, and when full-time leadership is non-negotiable. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/training-development-team-mdr https://zechmeister-solutions.com/en/blog/training-development-team-mdr Your whole team does not need to be regulatory experts, but everyone needs baseline MDR literacy. Here is the training curriculum that actually works. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cross-functional-teams-medtech https://zechmeister-solutions.com/en/blog/cross-functional-teams-medtech R&D, Regulatory Affairs, and Quality Assurance must work together from day one. Here is how to structure cross-functional MedTech teams that actually ship. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/remote-teams-mdr-compliance https://zechmeister-solutions.com/en/blog/remote-teams-mdr-compliance How distributed MedTech startups run a compliant QMS, handle document control, and survive Notified Body audits on remote teams MDR compliance. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-affairs-career-path-attracting-talent https://zechmeister-solutions.com/en/blog/regulatory-affairs-career-path-attracting-talent Where MedTech regulatory affairs talent comes from, what they want, and how a startup can compete with big pharma on the regulatory affairs career path. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/outsourcing-regulatory-work-consultants https://zechmeister-solutions.com/en/blog/outsourcing-regulatory-work-consultants How to choose, contract, and manage external MDR regulatory consultants without losing accountability under MDR Article 10. Red flags, contracts, qualification. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/cro-medtech-startup https://zechmeister-solutions.com/en/blog/cro-medtech-startup When and how to use a Contract Research Organization for MDR clinical investigations, what to delegate, and what the manufacturer can never hand off. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/working-with-cmos-mdr-startup https://zechmeister-solutions.com/en/blog/working-with-cmos-mdr-startup A contract manufacturer under MDR is an outsourced process requiring specific oversight. Here is how to choose and manage a CMO as a MedTech startup. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/supplier-qualification-medtech-startup https://zechmeister-solutions.com/en/blog/supplier-qualification-medtech-startup A risk-based playbook for selecting and qualifying suppliers under EN ISO 13485 clause 7.4 and MDR Article 10(9), written for resource-constrained startups. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/manufacturing-transfer-prototype-to-production https://zechmeister-solutions.com/en/blog/manufacturing-transfer-prototype-to-production What design transfer involves under EN ISO 13485 clause 7.3.8, the validation required at the production site, and the notified body notifications to plan. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/scaling-production-medical-devices-mdr https://zechmeister-solutions.com/en/blog/scaling-production-medical-devices-mdr How to scale medical device production from 10 to 10,000 units under MDR without breaking validation, supplier controls, or your notified body relationship. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/inventory-management-medical-devices https://zechmeister-solutions.com/en/blog/inventory-management-medical-devices Inventory management for medical devices under MDR: lot-level traceability, UDI, expiry control, quarantine, and recall readiness on a startup budget. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/distribution-strategy-medical-devices-europe https://zechmeister-solutions.com/en/blog/distribution-strategy-medical-devices-europe Direct sales, distributor partnership, or hybrid? Each has MDR obligations, cost trade-offs, and growth implications. Here is the choice framework. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/managing-distributors-importers-mdr https://zechmeister-solutions.com/en/blog/managing-distributors-importers-mdr What distributors and importers must do under MDR Articles 13, 14, and 16 — and what manufacturers must do to enable them. Includes the Article 16 trap. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/postmarket-service-support-operations https://zechmeister-solutions.com/en/blog/postmarket-service-support-operations How to run post-market service and support for medical devices under MDR: servicing as a regulated activity, records, traceability, complaint capture. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/customer-training-programs-mdr https://zechmeister-solutions.com/en/blog/customer-training-programs-mdr When customer training is a risk control under MDR, how to build compliant training programs, and how to document evidence that will survive audit. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/field-service-engineering-medical-devices https://zechmeister-solutions.com/en/blog/field-service-engineering-medical-devices Field service engineering under MDR: engineer competence, parts traceability, service reports feeding PMS, and the audit findings that trip up startups. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/knowledge-management-medtech-startups https://zechmeister-solutions.com/en/blog/knowledge-management-medtech-startups How MedTech startups retain regulatory know-how, reduce key-person risk, and turn documentation into a knowledge asset auditors trust. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/change-management-regulated-environments https://zechmeister-solutions.com/en/blog/change-management-regulated-environments How MedTech startups classify changes, decide what triggers Notified Body notification, and keep moving under MDR and EN ISO 13485. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/culture-of-quality-medtech-startup https://zechmeister-solutions.com/en/blog/culture-of-quality-medtech-startup How MedTech startups build a real culture of quality: hiring signals, daily practices, and the behaviors Notified Body auditors actually look for. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/project-management-regulated-product-development https://zechmeister-solutions.com/en/blog/project-management-regulated-product-development Regulated MedTech project management combines design controls, regulatory milestones, and lean execution. Here is the toolkit that works at startup scale. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/stakeholder-management-medtech-startups https://zechmeister-solutions.com/en/blog/stakeholder-management-medtech-startups Stakeholder management MedTech startup: what investors, Notified Bodies, clinical partners, and payers each need, and what Article 7 forbids you to say. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/strategic-partnerships-medtech https://zechmeister-solutions.com/en/blog/strategic-partnerships-medtech Strategic partnerships MedTech startup: when hospital, university and industry deals help, what Article 10 forbids you to delegate, and contract essentials. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-advisory-boards https://zechmeister-solutions.com/en/blog/medtech-startup-advisory-boards MedTech startup advisory board regulatory design: who should sit on it, how to structure engagements, and the Article 7 disclosure trap founders keep falling into. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/insurance-medtech-startups https://zechmeister-solutions.com/en/blog/insurance-medtech-startups What insurance MedTech startups actually need: product liability, clinical trial, D&O, and professional indemnity coverage under MDR. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/legal-considerations-medtech-startups https://zechmeister-solutions.com/en/blog/legal-considerations-medtech-startups Contracts, IP, and liability allocation for MedTech startups: the legal essentials that connect MDR obligations to commercial agreements. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/scaling-medtech-startup-operations https://zechmeister-solutions.com/en/blog/scaling-medtech-startup-operations What breaks in MedTech operations as you grow from 10 to 30 to 100 employees, and how your QMS and MDR obligations evolve with headcount. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/medtech-startup-operations-playbook-3-to-30 https://zechmeister-solutions.com/en/blog/medtech-startup-operations-playbook-3-to-30 Scaling a MedTech startup from 3 people to 30 is where most teams break their QMS. Here is the operations playbook that keeps compliance scaling with headcount. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prepare-medtech-acquisition-due-diligence https://zechmeister-solutions.com/en/blog/prepare-medtech-acquisition-due-diligence A 6-12 month founder-side playbook to prepare your MedTech startup for acquisition: data room, evidence audit, fixing red flags before diligence. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/prepare-medtech-acquisition-regulatory-due-diligence https://zechmeister-solutions.com/en/blog/prepare-medtech-acquisition-regulatory-due-diligence M&A due diligence in MedTech scrutinises regulatory assets and QMS health. Here is what acquirers look for and how to prepare the data room. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdcg-guidance-legally-binding https://zechmeister-solutions.com/en/blog/mdcg-guidance-legally-binding MDCG guidance is not legally binding, but notified bodies treat it as the reference interpretation of MDR. Here's how the legal hierarchy actually works. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/non-eu-guidance-mdr-fda-imdrf-aami https://zechmeister-solutions.com/en/blog/non-eu-guidance-mdr-fda-imdrf-aami Non-EU guidance documents are not recognised under MDR but can support state-of-the-art arguments. Here is when FDA, IMDRF and AAMI help and when they don't. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/national-laws-on-top-of-mdr https://zechmeister-solutions.com/en/blog/national-laws-on-top-of-mdr National laws on top of MDR add language, advertising, clinical investigation, and reimbursement rules across EU Member States. Plan for the patchwork. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/placing-on-market-vs-putting-into-service https://zechmeister-solutions.com/en/blog/placing-on-market-vs-putting-into-service Placing on market vs putting into service MDR: Article 2(28), 2(29), 2(31) definitions drive transitional provisions and deadlines for your device. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/switching-notified-bodies-mdr-article-58 https://zechmeister-solutions.com/en/blog/switching-notified-bodies-mdr-article-58 Switching notified bodies MDR Article 58: the voluntary change process, the agreement-between-NBs requirement, and how to avoid certification gaps. MDR Fundamentals & Regulatory Strategy office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/class-i-special-is-im-ir https://zechmeister-solutions.com/en/blog/class-i-special-is-im-ir Class I Is, Im, and Ir devices still need a Notified Body under MDR Article 52(7). What that actually means for startups and budgets. Device Classification & Conformity office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/pre-clinical-trial-readiness-mdr https://zechmeister-solutions.com/en/blog/pre-clinical-trial-readiness-mdr Before a clinical investigation under MDR Article 62, Annex XV requires a full pre-clinical evidence stack. Here is what that actually looks like. Clinical Evaluation & Investigations office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/imdrf-adverse-event-terminology-coding https://zechmeister-solutions.com/en/blog/imdrf-adverse-event-terminology-coding IMDRF Adverse Event Terminology is how Eudamed codes vigilance data. Here is how to build the lookup into your complaint intake before you need it. Post-Market Surveillance & Vigilance office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-monitoring-mdr-process https://zechmeister-solutions.com/en/blog/regulatory-monitoring-mdr-process A documented regulatory monitoring MDR process: how to track amendments, MDCG releases, and standard updates, and turn signals into action. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/gemba-walks-medtech-manufacturing https://zechmeister-solutions.com/en/blog/gemba-walks-medtech-manufacturing GEMBA walks in MedTech manufacturing under MDR: frequency, what to observe, and how to record findings as continuous-improvement evidence. Quality Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/iso-14971-annex-z-trap https://zechmeister-solutions.com/en/blog/iso-14971-annex-z-trap ISO 14971 Annex Z MDR risk reduction: why the global ISO version does not satisfy MDR, and what AFAP means in practice for EU manufacturers. Risk Management Under MDR office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/in-house-vs-accredited-labs-iso-17025 https://zechmeister-solutions.com/en/blog/in-house-vs-accredited-labs-iso-17025 When in-house testing is acceptable under MDR and when an ISO/IEC 17025 accredited lab is effectively mandatory for startup evidence. Electrical Safety & Systems Engineering office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/founders-emotional-journey-mdr https://zechmeister-solutions.com/en/blog/founders-emotional-journey-mdr Five stages most MedTech founders move through on the MDR path: denial, shock, anger, bargaining, acceptance — and what to do at each one. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/mdr-as-competitive-moat https://zechmeister-solutions.com/en/blog/mdr-as-competitive-moat How MDR certification becomes a durable competitive moat for MedTech startups — and how to position it correctly in fundraising and strategy. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/subtraction-audit-regulated-products https://zechmeister-solutions.com/en/blog/subtraction-audit-regulated-products A subtraction audit for MedTech: cut every feature that does not improve experience, speed, revenue, or regulatory necessity before it eats your budget. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/intended-purpose-trap-zweckbestimmung https://zechmeister-solutions.com/en/blog/intended-purpose-trap-zweckbestimmung The intended purpose trap is the number one MedTech startup killer. Why wrong Zweckbestimmung under MDR Article 2(12) cascades into class, claims, and CER scope. MedTech Startup Strategy & PMF office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/regulatory-costs-as-cogs https://zechmeister-solutions.com/en/blog/regulatory-costs-as-cogs Treat regulatory costs as COGS, not one-off CapEx. Why MDR Article 10 obligations belong in MedTech unit economics and how to model them honestly. Funding, Business Models & Reimbursement office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/soft-skills-regulatory-affairs https://zechmeister-solutions.com/en/blog/soft-skills-regulatory-affairs The unwritten skill stack that makes an MDR regulatory affairs professional effective: NB diplomacy, internal pushback, executive translation, documentation clarity. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000 https://zechmeister-solutions.com/en/blog/hard-skills-regulatory-affairs https://zechmeister-solutions.com/en/blog/hard-skills-regulatory-affairs The 12 technical hard skills every MDR regulatory affairs professional needs: MDR text fluency, ISO 13485, EN ISO 14971, classification, CER, vigilance, more. Team Building, Operations & Scaling office@zechmeister-solutions.com (Tibor Zechmeister and Felix Lenhard) Sat, 11 Apr 2026 07:59:50 +0000